Select features to define your cohort
Patient ID | Age at Diagnosis | Sex | Race | Definition | Menopausal Status | Cancer Type | ER | PR | HER2 | Event | Event Site | Survival Status | Survival Time (years) | Subtype | Genetic Ancestry | hidden |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TCGA-A7-A13G | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | new primary | skin | alive | 1.97 | LumA | European | TCGA.A7.A13G.01A.11R.A13Q.07 |
TCGA-A7-A13G | 79 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | new primary | skin | alive | 1.97 | LumA | European | TCGA.A7.A13G.11A.51R.A13Q.07 |
TCGA-E2-A14R | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | new primary | endometrial | alive | 2.31 | Basal | European | TCGA.E2.A14R.01A.11R.A115.07 |
TCGA-BH-A18V | 48 | female | White | Primary solid Tumor | not available | IDC | negative | negative | negative | metastasis | intramammary node | dead | 4.26 | Basal | European | TCGA.BH.A18V.01A.11R.A12D.07 |
TCGA-BH-A18V | 48 | female | White | Solid Tissue Normal | not available | IDC | negative | negative | negative | metastasis | intramammary node | dead | 4.26 | Basal | European | TCGA.BH.A18V.11A.52R.A12D.07 |
TCGA-E9-A1NI | 51 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | NA | NA | European | TCGA.E9.A1NI.01A.11R.A14D.07 |
TCGA-A2-A25D | 90 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | NA | LumA | European | TCGA.A2.A25D.01A.12R.A16F.07 |
TCGA-A8-A06N | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | NA | LumB | European | TCGA.A8.A06N.01A.11R.A00Z.07 |
TCGA-A8-A081 | 80 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | LumB | European | TCGA.A8.A081.01A.11R.A00Z.07 |
TCGA-A8-A083 | 67 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | LumA | European | TCGA.A8.A083.01A.21R.A00Z.07 |
TCGA-A8-A08H | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | Normal | European | TCGA.A8.A08H.01A.21R.A00Z.07 |
TCGA-A8-A090 | 74 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | LumA | European | TCGA.A8.A090.01A.11R.A00Z.07 |
TCGA-A8-A094 | 75 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | NA | Her2 | European | TCGA.A8.A094.01A.11R.A00Z.07 |
TCGA-A8-A096 | 73 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | LumB | European | TCGA.A8.A096.01A.11R.A00Z.07 |
TCGA-A8-A09G | 79 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | NA | Her2 | European | TCGA.A8.A09G.01A.21R.A00Z.07 |
TCGA-A8-A09Z | 83 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | NA | LumB | European | TCGA.A8.A09Z.01A.11R.A00Z.07 |
TCGA-AC-A3W6 | 90 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | NA | NA | European | TCGA.AC.A3W6.01A.12R.A22K.07 |
TCGA-C8-A12T | 43 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | Her2 | East Asian | TCGA.C8.A12T.01A.11R.A115.07 |
TCGA-C8-A26Y | 90 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | NA | Her2 | East Asian | TCGA.C8.A26Y.01A.11R.A16F.07 |
TCGA-D8-A1JK | 90 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | NA | Basal | European | TCGA.D8.A1JK.01A.11R.A13Q.07 |
TCGA-AC-A7VC | 56 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | NA | Basal | European | TCGA.AC.A7VC.01A.11R.A352.07 |
TCGA-AN-A0AM | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.01 | LumB | European | TCGA.AN.A0AM.01A.11R.A034.07 |
TCGA-C8-A1HJ | 53 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.01 | Basal | East Asian | TCGA.C8.A1HJ.01A.11R.A13Q.07 |
TCGA-E9-A1N4 | 41 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 0.01 | NA | European | TCGA.E9.A1N4.01A.11R.A14M.07 |
TCGA-E9-A1N4 | 41 | female | White | Solid Tissue Normal | premenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 0.01 | NA | European | TCGA.E9.A1N4.11A.33R.A14M.07 |
TCGA-C8-A273 | 29 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | LumA | East Asian | TCGA.C8.A273.01A.11R.A16F.07 |
TCGA-AN-A041 | 29 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.02 | LumA | European_admix | TCGA.AN.A041.01A.11R.A034.07 |
TCGA-C8-A12W | 49 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | LumB | East Asian | TCGA.C8.A12W.01A.11R.A115.07 |
TCGA-C8-A1HK | 53 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.02 | Her2 | East Asian | TCGA.C8.A1HK.01A.21R.A13Q.07 |
TCGA-C8-A3M8 | 68 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.02 | LumB | East Asian | TCGA.C8.A3M8.01A.11R.A213.07 |
TCGA-C8-A8HP | 59 | female | Asian | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | positive | NA | NA | alive | 0.02 | Her2 | East Asian | TCGA.C8.A8HP.01A.11R.A36F.07 |
TCGA-E9-A5FL | 65 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | 0.02 | Basal | European | TCGA.E9.A5FL.01A.11R.A27Q.07 |
TCGA-AC-A5XU | 74 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 0.02 | LumA | African | TCGA.AC.A5XU.01A.11R.A28M.07 |
TCGA-AN-A0XP | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.02 | LumA | European | TCGA.AN.A0XP.01A.11R.A109.07 |
TCGA-C8-A26V | 47 | female | Asian | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | LumB | East Asian | TCGA.C8.A26V.01A.11R.A16F.07 |
TCGA-C8-A278 | 61 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.02 | Her2 | East Asian | TCGA.C8.A278.01A.11R.A169.07 |
TCGA-C8-A8HQ | 53 | female | Asian | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.02 | NA | East Asian | TCGA.C8.A8HQ.01A.11R.A36F.07 |
TCGA-AN-A03X | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A03X.01A.21R.A00Z.07 |
TCGA-AN-A03Y | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | LumB | European | TCGA.AN.A03Y.01A.21R.A00Z.07 |
TCGA-AN-A046 | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A046.01A.21R.A034.07 |
TCGA-AN-A0AR | 55 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | Basal | European | TCGA.AN.A0AR.01A.11R.A00Z.07 |
TCGA-AN-A0AS | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0AS.01A.11R.A00Z.07 |
TCGA-AN-A0AT | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | Basal | European | TCGA.AN.A0AT.01A.11R.A034.07 |
TCGA-AN-A0FV | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.03 | Her2 | European | TCGA.AN.A0FV.01A.11R.A00Z.07 |
TCGA-AN-A0FX | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.03 | Basal | European | TCGA.AN.A0FX.01A.11R.A034.07 |
TCGA-AN-A0FY | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | LumB | European | TCGA.AN.A0FY.01A.11R.A034.07 |
TCGA-AN-A0FZ | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0FZ.01A.11R.A034.07 |
TCGA-AN-A0XN | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0XN.01A.21R.A109.07 |
TCGA-AN-A0XR | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | LumB | European | TCGA.AN.A0XR.01A.11R.A109.07 |
TCGA-AN-A0XS | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0XS.01A.22R.A109.07 |
TCGA-AN-A0XT | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0XT.01A.11R.A109.07 |
TCGA-AN-A0XU | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | Basal | European | TCGA.AN.A0XU.01A.11R.A109.07 |
TCGA-E2-A1IL | 78 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.04 | LumA | European | TCGA.E2.A1IL.01A.11R.A14D.07 |
TCGA-AN-A0G0 | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.04 | NA | European | TCGA.AN.A0G0.01A.11R.A034.07 |
TCGA-AN-A049 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.05 | LumA | European | TCGA.AN.A049.01A.21R.A00Z.07 |
TCGA-E9-A227 | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.07 | LumA | European | TCGA.E9.A227.01A.11R.A157.07 |
TCGA-A8-A08A | 89 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | LumA | European | TCGA.A8.A08A.01A.11R.A32Y.07 |
TCGA-A8-A09W | 70 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A09W.01A.11R.A00Z.07 |
TCGA-A8-A0A7 | 57 | female | not available | Primary solid Tumor | postmenopausal | ILC | negative | negative | positive | NA | NA | alive | 0.08 | Her2 | European | TCGA.A8.A0A7.01A.11R.A00Z.07 |
TCGA-A8-A06Q | 63 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A06Q.01A.11R.A034.07 |
TCGA-A8-A06Z | 84 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A06Z.01A.11R.A00Z.07 |
TCGA-A8-A09C | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A09C.01A.11R.A00Z.07 |
TCGA-A8-A09N | 57 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A09N.01A.11R.A00Z.07 |
TCGA-AC-A2QH | 58 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | 0.08 | Basal | European | TCGA.AC.A2QH.01A.11R.A18M.07 |
TCGA-AC-A8OR | 75 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.11 | NA | European | TCGA.AC.A8OR.01A.21R.A41B.07 |
TCGA-AC-A2FB | 65 | female | White | Primary solid Tumor | not available | ILC | positive | positive | positive | NA | NA | alive | 0.12 | LumA | European | TCGA.AC.A2FB.01A.11R.A17B.07 |
TCGA-AC-A2FB | 65 | female | White | Solid Tissue Normal | not available | ILC | positive | positive | positive | NA | NA | alive | 0.12 | LumA | European | TCGA.AC.A2FB.11A.13R.A17B.07 |
TCGA-D8-A27P | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.13 | LumA | European | TCGA.D8.A27P.01A.11R.A16F.07 |
TCGA-D8-A1XS | 48 | male | White | Primary solid Tumor | not applicable | ductal/micropapillary | positive | positive | positive | NA | NA | alive | 0.14 | NA | European | TCGA.D8.A1XS.01A.11R.A14M.07 |
TCGA-AC-A6NO | 43 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | negative | NA | NA | alive | 0.14 | LumA | African_admix | TCGA.AC.A6NO.01A.12R.A33J.07 |
TCGA-AN-A04D | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.14 | Basal | European | TCGA.AN.A04D.01A.21R.A034.07 |
TCGA-A7-A3RF | 79 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | metastasis | bone>liver | alive | 0.15 | NA | European | TCGA.A7.A3RF.01A.11R.A22K.07 |
TCGA-AN-A04C | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.15 | Her2 | European | TCGA.AN.A04C.01A.21R.A034.07 |
TCGA-AC-A62Y | 79 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.15 | LumA | European | TCGA.AC.A62Y.01A.11R.A29R.07 |
TCGA-BH-A18G | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.17 | Basal | European | TCGA.BH.A18G.01A.11R.A12D.07 |
TCGA-AC-A5EH | 76 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | negative | negative | NA | NA | alive | 0.17 | Her2 | African_admix | TCGA.AC.A5EH.01A.11R.A28M.07 |
TCGA-OK-A5Q2 | 59 | female | not available | Primary solid Tumor | unknown | ILC | positive | positive | negative | NA | NA | alive | 0.18 | LumA | African | TCGA.OK.A5Q2.01A.11R.A27Q.07 |
TCGA-A7-A26J | 49 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.19 | LumA | European | TCGA.A7.A26J.01A.11R.A169.07 |
TCGA-C8-A131 | 82 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.19 | Basal | East Asian | TCGA.C8.A131.01A.11R.A115.07 |
TCGA-AC-A8OS | 71 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.19 | LumA | European | TCGA.AC.A8OS.01A.12R.A41B.07 |
TCGA-C8-A1HM | 74 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.19 | LumB | East Asian | TCGA.C8.A1HM.01A.12R.A137.07 |
TCGA-D8-A27V | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.2 | LumA | European | TCGA.D8.A27V.01A.12R.A17B.07 |
TCGA-A7-A3J1 | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.21 | NA | European | TCGA.A7.A3J1.01A.11R.A213.07 |
TCGA-D8-A1XG | 86 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.21 | LumA | European | TCGA.D8.A1XG.01A.11R.A14D.07 |
TCGA-A7-A3J0 | 62 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.21 | NA | European | TCGA.A7.A3J0.01A.11R.A213.07 |
TCGA-BH-A0HO | 48 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.21 | LumA | European | TCGA.BH.A0HO.01A.11R.A034.07 |
TCGA-BH-A0DS | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.21 | LumA | European | TCGA.BH.A0DS.01A.11R.A056.07 |
TCGA-HN-A2NL | 56 | female | not available | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | NA | NA | alive | 0.22 | Basal | European | TCGA.HN.A2NL.01A.11R.A18M.07 |
TCGA-LL-A6FQ | 77 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.22 | LumA | African | TCGA.LL.A6FQ.01A.11R.A31O.07 |
TCGA-D8-A1XY | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.22 | LumA | European | TCGA.D8.A1XY.01A.11R.A14M.07 |
TCGA-D8-A1X7 | 40 | female | White | Primary solid Tumor | premenopausal | ductal partially papillary | positive | positive | negative | NA | NA | alive | 0.23 | NA | European | TCGA.D8.A1X7.01A.11R.A14M.07 |
TCGA-MS-A51U | 44 | female | White | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 0.23 | NA | European | TCGA.MS.A51U.01A.31R.A266.07 |
TCGA-AN-A04A | 36 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.25 | LumA | European | TCGA.AN.A04A.01A.21R.A034.07 |
TCGA-E9-A6HE | 45 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.25 | LumA | European | TCGA.E9.A6HE.01A.11R.A31O.07 |
TCGA-D8-A1JF | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.26 | Her2 | European | TCGA.D8.A1JF.01A.11R.A13Q.07 |
TCGA-D8-A1XF | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | LumB | European | TCGA.D8.A1XF.01A.11R.A14D.07 |
TCGA-LL-A5YO | 50 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.27 | Her2 | African | TCGA.LL.A5YO.01A.21R.A28M.07 |
TCGA-BH-A0DQ | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | LumA | European | TCGA.BH.A0DQ.01A.11R.A084.07 |
TCGA-BH-A0DQ | 42 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | LumA | European | TCGA.BH.A0DQ.11A.12R.A089.07 |
TCGA-BH-A5IZ | 51 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.27 | Basal | African | TCGA.BH.A5IZ.01A.11R.A27Q.07 |
TCGA-LL-A7T0 | 70 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.27 | LumB | African | TCGA.LL.A7T0.01A.31R.A352.07 |
TCGA-LL-A5YP | 49 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.27 | Basal | African | TCGA.LL.A5YP.01A.21R.A28M.07 |
TCGA-BH-A0E0 | 38 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.37 | Basal | European | TCGA.BH.A0E0.01A.11R.A056.07 |
TCGA-BH-A0E0 | 38 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.37 | Basal | European | TCGA.BH.A0E0.11A.13R.A089.07 |
TCGA-BH-A6R9 | 61 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | positive | negative | NA | NA | alive | 0.44 | Normal | European | TCGA.BH.A6R9.01A.21R.A32P.07 |
TCGA-AN-A0XV | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.44 | LumA | European | TCGA.AN.A0XV.01A.11R.A109.07 |
TCGA-AN-A0XL | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.45 | LumA | European | TCGA.AN.A0XL.01A.11R.A10J.07 |
TCGA-AN-A0XW | 36 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.47 | LumA | European | TCGA.AN.A0XW.01A.11R.A109.07 |
TCGA-BH-A0RX | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.47 | Basal | European | TCGA.BH.A0RX.01A.21R.A084.07 |
TCGA-AN-A0FF | 32 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.47 | LumB | European | TCGA.AN.A0FF.01A.11R.A034.07 |
TCGA-BH-A0HK | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.49 | LumA | European | TCGA.BH.A0HK.01A.11R.A056.07 |
TCGA-BH-A0HK | 81 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.49 | LumA | European | TCGA.BH.A0HK.11A.11R.A089.07 |
TCGA-EW-A1PC | 66 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.51 | NA | African | TCGA.EW.A1PC.01B.11R.A21T.07 |
TCGA-AN-A0FD | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.54 | LumA | European | TCGA.AN.A0FD.01A.11R.A034.07 |
TCGA-BH-A28Q | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.54 | LumA | European | TCGA.BH.A28Q.01A.11R.A16F.07 |
TCGA-AN-A0FS | 55 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | negative | positive | NA | NA | alive | 0.57 | LumA | European | TCGA.AN.A0FS.01A.11R.A034.07 |
TCGA-AN-A0FK | 88 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.58 | LumA | European | TCGA.AN.A0FK.01A.11R.A034.07 |
TCGA-AN-A0FT | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.59 | LumA | European | TCGA.AN.A0FT.01A.11R.A034.07 |
TCGA-B6-A400 | 43 | female | Black or African American | Primary solid Tumor | unknown | IDC | negative | negative | negative | NA | NA | alive | 0.59 | NA | African | TCGA.B6.A400.01A.11R.A239.07 |
TCGA-LD-A7W5 | 52 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.59 | LumA | African | TCGA.LD.A7W5.01A.22R.A352.07 |
TCGA-AN-A0FN | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.6 | LumA | European | TCGA.AN.A0FN.01A.11R.A034.07 |
TCGA-BH-A18I | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.6 | LumA | European | TCGA.BH.A18I.01A.11R.A12D.07 |
TCGA-A2-A4RW | 49 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.61 | NA | European | TCGA.A2.A4RW.01A.21R.A266.07 |
TCGA-AN-A0AK | 76 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.61 | LumB | European | TCGA.AN.A0AK.01A.21R.A00Z.07 |
TCGA-GI-A2C8 | 63 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 0.62 | LumA | European | TCGA.GI.A2C8.01A.11R.A16F.07 |
TCGA-GI-A2C8 | 63 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | alive | 0.62 | LumA | European | TCGA.GI.A2C8.11A.22R.A16F.07 |
TCGA-AN-A0AL | 41 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.62 | Basal | European | TCGA.AN.A0AL.01A.11R.A00Z.07 |
TCGA-A7-A0CG | 78 | female | White | Primary solid Tumor | postmenopausal | ILC/IDC (grade 1) | positive | negative | negative | NA | NA | alive | 0.63 | NA | European | TCGA.A7.A0CG.01A.12R.A056.07 |
TCGA-AN-A0FL | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.63 | Basal | European | TCGA.AN.A0FL.01A.11R.A034.07 |
TCGA-A1-A0SM | 77 | male | White | Primary solid Tumor | not applicable | IDC | positive | negative | positive | NA | NA | alive | 0.66 | NA | European | TCGA.A1.A0SM.01A.11R.A084.07 |
TCGA-AN-A0FJ | 59 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.66 | Basal | European | TCGA.AN.A0FJ.01A.11R.A00Z.07 |
TCGA-EW-A1IY | 38 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.71 | LumB | East Asian | TCGA.EW.A1IY.01A.11R.A13Q.07 |
TCGA-A1-A0SB | 70 | female | White | Primary solid Tumor | postmenopausal | adenoid cystic carcinoma | positive | negative | negative | NA | NA | alive | 0.71 | NA | European | TCGA.A1.A0SB.01A.11R.A144.07 |
TCGA-A7-A6VY | 48 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.73 | Basal | African_admix | TCGA.A7.A6VY.01A.12R.A33J.07 |
TCGA-A7-A0DB | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.73 | LumA | European | TCGA.A7.A0DB.01A.11R.A00Z.07 |
TCGA-A7-A0DB | 56 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.73 | LumA | European | TCGA.A7.A0DB.11A.33R.A089.07 |
TCGA-BH-A18F | 50 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.73 | LumA | European | TCGA.BH.A18F.01A.11R.A12D.07 |
TCGA-A7-A0D9 | 37 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.75 | LumA | European | TCGA.A7.A0D9.01A.31R.A056.07 |
TCGA-A7-A0D9 | 37 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.75 | LumA | European | TCGA.A7.A0D9.11A.53R.A089.07 |
TCGA-A8-A07R | 80 | female | not available | Primary solid Tumor | not available | IDC | negative | negative | positive | NA | NA | alive | 0.75 | NA | European | TCGA.A8.A07R.01A.21R.A034.07 |
TCGA-A8-A09R | 82 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.75 | LumB | European | TCGA.A8.A09R.01A.11R.A00Z.07 |
TCGA-A8-A079 | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.75 | LumB | European | TCGA.A8.A079.01A.21R.A00Z.07 |
TCGA-A7-A6VW | 48 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.78 | Basal | African_admix | TCGA.A7.A6VW.01A.21R.A33J.07 |
TCGA-BH-AB28 | 53 | female | White | Primary solid Tumor | unknown | ILC | positive | positive | negative | NA | NA | alive | 0.79 | LumA | European | TCGA.BH.AB28.01A.31R.A41B.07 |
TCGA-D8-A27K | 47 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.79 | LumA | European | TCGA.D8.A27K.01A.11R.A16F.07 |
TCGA-AO-A0J4 | 41 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.8 | Basal | African | TCGA.AO.A0J4.01A.11R.A034.07 |
TCGA-AN-A0AJ | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.83 | LumB | European | TCGA.AN.A0AJ.01A.11R.A00Z.07 |
TCGA-A8-A07O | 51 | female | not available | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.83 | Basal | European | TCGA.A8.A07O.01A.11R.A00Z.07 |
TCGA-A8-A07W | 76 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.83 | LumB | European | TCGA.A8.A07W.01A.11R.A00Z.07 |
TCGA-A8-A099 | 76 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.83 | LumA | European | TCGA.A8.A099.01A.11R.A00Z.07 |
TCGA-A8-A09A | 40 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.83 | LumA | European | TCGA.A8.A09A.01A.11R.A00Z.07 |
TCGA-A7-A6VV | 51 | female | Black or African American | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.86 | Basal | African | TCGA.A7.A6VV.01A.22R.A33J.07 |
TCGA-A7-A6VX | 68 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.87 | LumB | African | TCGA.A7.A6VX.01A.12R.A33J.07 |
TCGA-A2-A25F | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 0.88 | Basal | European | TCGA.A2.A25F.01A.11R.A169.07 |
TCGA-LD-A9QF | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.88 | Normal | African_admix | TCGA.LD.A9QF.01A.32R.A41B.07 |
TCGA-BH-A28O | 50 | female | White | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 0.89 | NA | European | TCGA.BH.A28O.01A.11R.A22K.07 |
TCGA-A7-A5ZW | 47 | female | Black or African American | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.89 | LumA | African_admix | TCGA.A7.A5ZW.01A.12R.A29R.07 |
TCGA-AC-A23G | 76 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.9 | NA | European | TCGA.AC.A23G.01A.11R.A213.07 |
TCGA-C8-A1HF | 48 | female | Asian | Primary solid Tumor | premenopausal | IDC | negative | positive | positive | NA | NA | alive | 0.91 | Her2 | East Asian | TCGA.C8.A1HF.01A.11R.A137.07 |
TCGA-A8-A07P | 68 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.91 | LumA | European | TCGA.A8.A07P.01A.11R.A00Z.07 |
TCGA-A7-A5ZX | 48 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.92 | LumA | European | TCGA.A7.A5ZX.01A.12R.A29R.07 |
TCGA-E2-A1IU | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.92 | LumA | European | TCGA.E2.A1IU.01A.11R.A14D.07 |
TCGA-C8-A1HI | 40 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.94 | LumA | East Asian | TCGA.C8.A1HI.01A.11R.A137.07 |
TCGA-A7-A3IY | 71 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.94 | NA | European | TCGA.A7.A3IY.01A.21R.A21T.07 |
TCGA-C8-A1HG | 50 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.94 | LumB | East Asian | TCGA.C8.A1HG.01A.11R.A137.07 |
TCGA-W8-A86G | 66 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.95 | LumA | European | TCGA.W8.A86G.01A.21R.A36F.07 |
TCGA-JL-A3YX | 46 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.96 | LumA | South Asian_admix | TCGA.JL.A3YX.01A.11R.A22U.07 |
TCGA-C8-A12M | 70 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.98 | LumB | East Asian | TCGA.C8.A12M.01A.11R.A115.07 |
TCGA-C8-A12N | 58 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.98 | LumA | East Asian | TCGA.C8.A12N.01A.11R.A115.07 |
TCGA-C8-A12P | 55 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.98 | Her2 | East Asian | TCGA.C8.A12P.01A.11R.A115.07 |
TCGA-JL-A3YW | 49 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.99 | NA | South Asian | TCGA.JL.A3YW.01A.12R.A239.07 |
TCGA-D8-A13Y | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.99 | LumB | European | TCGA.D8.A13Y.01A.11R.A115.07 |
TCGA-A7-A426 | 50 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.0 | NA | European | TCGA.A7.A426.01A.22R.A24H.07 |
TCGA-A8-A07J | 35 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.0 | LumA | European | TCGA.A8.A07J.01A.11R.A00Z.07 |
TCGA-A8-A08I | 53 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.0 | LumB | European | TCGA.A8.A08I.01A.11R.A00Z.07 |
TCGA-A8-A097 | 65 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.0 | LumA | European | TCGA.A8.A097.01A.11R.A034.07 |
TCGA-A8-A09B | 58 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.0 | LumA | European | TCGA.A8.A09B.01A.11R.A00Z.07 |
TCGA-A8-A0A1 | 84 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.0 | LumA | European | TCGA.A8.A0A1.01A.11R.A00Z.07 |
TCGA-D8-A1JS | 77 | female | White | Primary solid Tumor | postmenopausal | papillary | positive | positive | negative | NA | NA | alive | 1.02 | NA | European | TCGA.D8.A1JS.01A.11R.A13Q.07 |
TCGA-EW-A1IW | 80 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.02 | LumA | European | TCGA.EW.A1IW.01A.11R.A13Q.07 |
TCGA-A7-A0DA | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.02 | Basal | European | TCGA.A7.A0DA.01A.31R.A115.07 |
TCGA-AN-A0XO | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.03 | LumA | European | TCGA.AN.A0XO.01A.11R.A109.07 |
TCGA-C8-A1HO | 34 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.03 | LumA | East Asian | TCGA.C8.A1HO.01A.11R.A13Q.07 |
TCGA-E9-A295 | 71 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.03 | LumA | European | TCGA.E9.A295.01A.11R.A16F.07 |
TCGA-C8-A26X | 58 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.03 | Her2 | East Asian | TCGA.C8.A26X.01A.31R.A16F.07 |
TCGA-C8-A137 | 34 | female | Asian | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | locoregional recurrence | not available | alive | 1.04 | Her2 | East Asian | TCGA.C8.A137.01A.11R.A115.07 |
TCGA-C8-A12Z | 45 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.05 | Her2 | East Asian | TCGA.C8.A12Z.01A.11R.A115.07 |
TCGA-C8-A12O | 50 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.05 | LumA | East Asian | TCGA.C8.A12O.01A.11R.A115.07 |
TCGA-C8-A12U | 46 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.05 | LumB | East Asian | TCGA.C8.A12U.01A.11R.A115.07 |
TCGA-C8-A12V | 55 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.05 | Basal | East Asian | TCGA.C8.A12V.01A.11R.A115.07 |
TCGA-C8-A12X | 62 | female | Asian | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 1.05 | NA | East Asian | TCGA.C8.A12X.01A.11R.A115.07 |
TCGA-D8-A1XW | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 1.05 | Normal | European | TCGA.D8.A1XW.01A.11R.A14M.07 |
TCGA-BH-A0HU | 52 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.07 | LumB | European | TCGA.BH.A0HU.01A.11R.A034.07 |
TCGA-C8-A135 | 64 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.08 | Her2 | East Asian | TCGA.C8.A135.01A.11R.A115.07 |
TCGA-D8-A1XU | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | LumA | European | TCGA.D8.A1XU.01A.11R.A14M.07 |
TCGA-A8-A06O | 60 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | LumB | European | TCGA.A8.A06O.01A.11R.A00Z.07 |
TCGA-A8-A06P | 63 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | LumA | European | TCGA.A8.A06P.01A.11R.A00Z.07 |
TCGA-A8-A086 | 59 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | LumA | European | TCGA.A8.A086.01A.11R.A00Z.07 |
TCGA-A8-A09D | 47 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | LumA | European | TCGA.A8.A09D.01A.11R.A00Z.07 |
TCGA-A8-A0A4 | 73 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.08 | LumA | European | TCGA.A8.A0A4.01A.11R.A00Z.07 |
TCGA-D8-A27H | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.09 | Basal | European | TCGA.D8.A27H.01A.11R.A16F.07 |
TCGA-D8-A27T | 53 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.09 | LumA | European | TCGA.D8.A27T.01A.11R.A16F.07 |
TCGA-E9-A1N9 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | negative | positive | positive | NA | NA | alive | 1.09 | NA | European | TCGA.E9.A1N9.01A.11R.A14D.07 |
TCGA-E9-A1N9 | 58 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | negative | positive | positive | NA | NA | alive | 1.09 | NA | European | TCGA.E9.A1N9.11A.71R.A14D.07 |
TCGA-E9-A22D | 38 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.1 | LumB | European | TCGA.E9.A22D.01A.11R.A157.07 |
TCGA-LD-A74U | 79 | female | White | Primary solid Tumor | not available | \ILC, classical type, focal pleomorphic type\"" | positive | negative | negative | NA | NA | alive | 1.1 | NA | European | TCGA.LD.A74U.01A.13R.A33J.07 |
TCGA-D8-A140 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.1 | LumA | European | TCGA.D8.A140.01A.11R.A115.07 |
TCGA-EW-A1J2 | 50 | female | Black or African American | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.1 | LumA | South Asian | TCGA.EW.A1J2.01A.21R.A13Q.07 |
TCGA-LD-A7W6 | 54 | female | White | Primary solid Tumor | postmenopausal | \ILC, mixed classical (70%) and pleomorphic/solid (30%) types\"" | positive | positive | negative | NA | NA | alive | 1.11 | NA | European | TCGA.LD.A7W6.01A.81R.A352.07 |
TCGA-D8-A27M | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.12 | Basal | European | TCGA.D8.A27M.01A.11R.A16F.07 |
TCGA-AC-A6IW | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.13 | Basal | African | TCGA.AC.A6IW.01A.12R.A33J.07 |
TCGA-BH-A0HP | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.13 | LumA | European | TCGA.BH.A0HP.01A.12R.A084.07 |
TCGA-A7-A4SB | 56 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.14 | NA | European | TCGA.A7.A4SB.01A.21R.A266.07 |
TCGA-E9-A1NE | 28 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.15 | LumA | European | TCGA.E9.A1NE.01A.21R.A14M.07 |
TCGA-BH-A0DK | 49 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.16 | LumA | European | TCGA.BH.A0DK.01A.21R.A056.07 |
TCGA-BH-A0DK | 49 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.16 | LumA | European | TCGA.BH.A0DK.11A.13R.A089.07 |
TCGA-A8-A07I | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.17 | Her2 | European | TCGA.A8.A07I.01A.11R.A00Z.07 |
TCGA-D8-A1JH | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.17 | LumA | European | TCGA.D8.A1JH.01A.11R.A13Q.07 |
TCGA-D8-A143 | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.18 | Basal | European | TCGA.D8.A143.01A.11R.A115.07 |
TCGA-D8-A1J8 | 77 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.18 | LumB | European | TCGA.D8.A1J8.01A.11R.A13Q.07 |
TCGA-A1-A0SG | 61 | female | White | Primary solid Tumor | postmenopausal | micropapillary carcinoma invasive | positive | positive | negative | NA | NA | alive | 1.19 | NA | European | TCGA.A1.A0SG.01A.11R.A144.07 |
TCGA-BH-A0E2 | 49 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.19 | LumA | African | TCGA.BH.A0E2.01A.11R.A056.07 |
TCGA-A1-A0SD | 59 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 1.2 | LumA | European | TCGA.A1.A0SD.01A.11R.A115.07 |
TCGA-C8-A27B | 48 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.2 | Basal | East Asian | TCGA.C8.A27B.01A.11R.A169.07 |
TCGA-D8-A27I | 58 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.2 | LumA | European | TCGA.D8.A27I.01A.11R.A16F.07 |
TCGA-A2-A0YI | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.21 | LumA | European | TCGA.A2.A0YI.01A.31R.A10J.07 |
TCGA-D8-A1XK | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.21 | Basal | European | TCGA.D8.A1XK.01A.21R.A14M.07 |
TCGA-D8-A3Z5 | 54 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.21 | NA | European | TCGA.D8.A3Z5.01A.41R.A24H.07 |
TCGA-A2-A0YL | 48 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.22 | LumA | European | TCGA.A2.A0YL.01A.21R.A109.07 |
TCGA-D8-A1JU | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.22 | LumA | European | TCGA.D8.A1JU.01A.11R.A13Q.07 |
TCGA-A7-A56D | 84 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.23 | LumA | African | TCGA.A7.A56D.01A.11R.A27Q.07 |
TCGA-E2-A158 | 43 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.23 | Basal | European | TCGA.E2.A158.01A.11R.A12D.07 |
TCGA-E2-A158 | 43 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.23 | Basal | European | TCGA.E2.A158.11A.22R.A12D.07 |
TCGA-AC-A3OD | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.23 | LumA | European | TCGA.AC.A3OD.01A.11R.A21T.07 |
TCGA-A7-A4SA | 40 | female | White | Primary solid Tumor | premenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.24 | NA | European | TCGA.A7.A4SA.01A.11R.A266.07 |
TCGA-AC-A3TN | 75 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.25 | NA | European | TCGA.AC.A3TN.01A.11R.A22K.07 |
TCGA-A8-A09M | 75 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.25 | LumB | European | TCGA.A8.A09M.01A.11R.A00Z.07 |
TCGA-A8-A09V | 51 | female | not available | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.25 | LumA | European | TCGA.A8.A09V.01A.11R.A034.07 |
TCGA-A8-A084 | 81 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.25 | NA | European | TCGA.A8.A084.01A.21R.A00Z.07 |
TCGA-BH-A0H0 | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.26 | LumB | European | TCGA.BH.A0H0.01A.11R.A056.07 |
TCGA-EW-A6S9 | 34 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | alive | 1.27 | LumA | African_admix | TCGA.EW.A6S9.01A.22R.A33J.07 |
TCGA-D8-A1XZ | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.28 | LumB | European | TCGA.D8.A1XZ.01A.11R.A14M.07 |
TCGA-XX-A899 | 46 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.28 | LumA | European | TCGA.XX.A899.01A.11R.A36F.07 |
TCGA-A2-A0YF | 67 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.28 | LumA | African_admix | TCGA.A2.A0YF.01A.21R.A109.07 |
TCGA-C8-A26Z | 59 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.29 | LumA | East Asian | TCGA.C8.A26Z.01A.11R.A16F.07 |
TCGA-E2-A1LS | 46 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.29 | NA | European | TCGA.E2.A1LS.01A.12R.A157.07 |
TCGA-E2-A1LS | 46 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.29 | NA | European | TCGA.E2.A1LS.11A.32R.A157.07 |
TCGA-AC-A3W7 | 66 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.29 | NA | European | TCGA.AC.A3W7.01A.11R.A22K.07 |
TCGA-D8-A1Y0 | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.29 | LumA | European | TCGA.D8.A1Y0.01A.11R.A14M.07 |
TCGA-D8-A1XO | 56 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.3 | LumA | European | TCGA.D8.A1XO.01A.11R.A14M.07 |
TCGA-BH-A0DP | 60 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.3 | LumA | European | TCGA.BH.A0DP.01A.21R.A056.07 |
TCGA-BH-A0DP | 60 | female | White | Solid Tissue Normal | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.3 | LumA | European | TCGA.BH.A0DP.11A.12R.A089.07 |
TCGA-EW-A1J5 | 59 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.31 | LumA | European | TCGA.EW.A1J5.01A.11R.A13Q.07 |
TCGA-LL-A73Y | 67 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.31 | Basal | African | TCGA.LL.A73Y.01A.11R.A33J.07 |
TCGA-D8-A1JC | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.31 | LumB | European | TCGA.D8.A1JC.01A.11R.A13Q.07 |
TCGA-D8-A1XR | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.32 | LumB | European | TCGA.D8.A1XR.01A.11R.A14M.07 |
TCGA-A2-A0EY | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.33 | LumB | European | TCGA.A2.A0EY.01A.11R.A034.07 |
TCGA-E2-A14P | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.33 | Her2 | European | TCGA.E2.A14P.01A.31R.A12D.07 |
TCGA-AR-A5QN | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.34 | LumA | European | TCGA.AR.A5QN.01A.12R.A28M.07 |
TCGA-D8-A27F | 40 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.34 | Basal | European | TCGA.D8.A27F.01A.11R.A16F.07 |
TCGA-XX-A89A | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.34 | LumA | European | TCGA.XX.A89A.01A.11R.A36F.07 |
TCGA-D8-A73U | 88 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.35 | LumA | European | TCGA.D8.A73U.01A.11R.A33J.07 |
TCGA-BH-A0DZ | 43 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.36 | LumA | European | TCGA.BH.A0DZ.01A.11R.A00Z.07 |
TCGA-BH-A0DZ | 43 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.36 | LumA | European | TCGA.BH.A0DZ.11A.22R.A089.07 |
TCGA-AC-A3HN | 87 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.36 | LumA | European | TCGA.AC.A3HN.01A.11R.A213.07 |
TCGA-D8-A1XQ | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.37 | Basal | European | TCGA.D8.A1XQ.01A.11R.A14M.07 |
TCGA-D8-A27L | 49 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.37 | LumA | European | TCGA.D8.A27L.01A.11R.A16F.07 |
TCGA-A2-A1G6 | 50 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.37 | Normal | European | TCGA.A2.A1G6.01A.11R.A13Q.07 |
TCGA-E2-A1BC | 63 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.37 | LumA | European | TCGA.E2.A1BC.01A.11R.A12P.07 |
TCGA-E2-A1BC | 63 | female | not available | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.37 | LumA | European | TCGA.E2.A1BC.11A.32R.A12P.07 |
TCGA-D8-A1JA | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | locoregional disease | NA | alive | 1.37 | Her2 | European | TCGA.D8.A1JA.01A.11R.A13Q.07 |
TCGA-EW-A1J3 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.38 | LumA | European | TCGA.EW.A1J3.01A.11R.A13Q.07 |
TCGA-D8-A1XT | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.39 | Her2 | European | TCGA.D8.A1XT.01A.11R.A14M.07 |
TCGA-C8-A274 | 63 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.39 | LumB | East Asian | TCGA.C8.A274.01A.11R.A16F.07 |
TCGA-E9-A1N5 | 45 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 1.39 | NA | European | TCGA.E9.A1N5.01A.11R.A14D.07 |
TCGA-E9-A1N5 | 45 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 1.39 | NA | European | TCGA.E9.A1N5.11A.41R.A14D.07 |
TCGA-EW-A6SA | 59 | male | Black or African American | Primary solid Tumor | not applicable | IDC | positive | negative | negative | NA | NA | alive | 1.4 | NA | African | TCGA.EW.A6SA.01A.21R.A32P.07 |
TCGA-A8-A075 | 42 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.42 | LumB | European | TCGA.A8.A075.01A.11R.A084.07 |
TCGA-A8-A0AB | 54 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.42 | LumA | European | TCGA.A8.A0AB.01A.11R.A034.07 |
TCGA-UL-AAZ6 | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.42 | LumA | African | TCGA.UL.AAZ6.01A.11R.A41B.07 |
TCGA-D8-A27N | 36 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.42 | LumB | European | TCGA.D8.A27N.01A.11R.A16F.07 |
TCGA-LL-A5YL | 64 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | positive | NA | NA | alive | 1.42 | LumA | European | TCGA.LL.A5YL.01A.12R.A29R.07 |
TCGA-D8-A1XD | 36 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.43 | NA | European | TCGA.D8.A1XD.01A.11R.A14D.07 |
TCGA-A2-A25C | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.43 | LumB | European | TCGA.A2.A25C.01A.11R.A169.07 |
TCGA-BH-A0DO | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.44 | LumA | European | TCGA.BH.A0DO.01B.11R.A12D.07 |
TCGA-BH-A0DO | 78 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.44 | LumA | European | TCGA.BH.A0DO.11A.22R.A12D.07 |
TCGA-S3-AA15 | 51 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.44 | Basal | African | TCGA.S3.AA15.01A.11R.A41B.07 |
TCGA-A2-A1FW | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.45 | LumB | European | TCGA.A2.A1FW.01A.11R.A13Q.07 |
TCGA-S3-AA14 | 47 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.45 | LumA | African | TCGA.S3.AA14.01A.11R.A41B.07 |
TCGA-D8-A27E | 66 | female | White | Primary solid Tumor | postmenopausal | IDC/mucinous | positive | positive | negative | NA | NA | alive | 1.45 | NA | European | TCGA.D8.A27E.01A.11R.A16F.07 |
TCGA-A2-A0T5 | 39 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.45 | LumA | European | TCGA.A2.A0T5.01A.21R.A084.07 |
TCGA-D8-A1J9 | 48 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.46 | LumB | European | TCGA.D8.A1J9.01A.11R.A13Q.07 |
TCGA-EW-A3U0 | 61 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.46 | NA | African_admix | TCGA.EW.A3U0.01A.11R.A22K.07 |
TCGA-LL-A9Q3 | 69 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.46 | LumA | European | TCGA.LL.A9Q3.01A.11R.A41B.07 |
TCGA-A2-A0T0 | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.46 | Basal | European | TCGA.A2.A0T0.01A.22R.A084.07 |
TCGA-D8-A1XM | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.47 | LumA | European | TCGA.D8.A1XM.01A.21R.A14M.07 |
TCGA-D8-A1X6 | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.48 | LumB | European | TCGA.D8.A1X6.01A.11R.A14M.07 |
TCGA-A7-A4SF | 54 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.49 | NA | African | TCGA.A7.A4SF.01A.11R.A266.07 |
TCGA-A8-A093 | 61 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.49 | LumA | European | TCGA.A8.A093.01A.11R.A00Z.07 |
TCGA-A8-A06R | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.5 | LumB | European | TCGA.A8.A06R.01A.11R.A00Z.07 |
TCGA-A8-A082 | 58 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.5 | LumB | European | TCGA.A8.A082.01A.11R.A00Z.07 |
TCGA-A8-A08F | 59 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.5 | NA | European | TCGA.A8.A08F.01A.11R.A00Z.07 |
TCGA-GM-A5PX | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.51 | LumA | European | TCGA.GM.A5PX.01A.12R.A28M.07 |
TCGA-D8-A1JD | 41 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.51 | LumB | European | TCGA.D8.A1JD.01A.11R.A13Q.07 |
TCGA-D8-A1XB | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.51 | LumA | European | TCGA.D8.A1XB.01A.11R.A14D.07 |
TCGA-A1-A0SQ | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.52 | LumA | European | TCGA.A1.A0SQ.01A.21R.A144.07 |
TCGA-A2-A0YE | 48 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.52 | Basal | European | TCGA.A2.A0YE.01A.11R.A109.07 |
TCGA-BH-A0BD | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.52 | LumB | European | TCGA.BH.A0BD.01A.11R.A034.07 |
TCGA-E2-A15G | 76 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 1.52 | NA | European | TCGA.E2.A15G.01A.11R.A12D.07 |
TCGA-BH-A0W7 | 49 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 1.53 | LumA | European | TCGA.BH.A0W7.01A.11R.A115.07 |
TCGA-EW-A1P6 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.54 | LumA | European | TCGA.EW.A1P6.01A.11R.A144.07 |
TCGA-S3-A6ZG | 71 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 1.54 | NA | African_admix | TCGA.S3.A6ZG.01A.22R.A32P.07 |
TCGA-D8-A3Z6 | 56 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.54 | LumA | European | TCGA.D8.A3Z6.01A.11R.A239.07 |
TCGA-D8-A1X5 | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.55 | LumB | European | TCGA.D8.A1X5.01A.11R.A14D.07 |
TCGA-A2-A0YJ | 39 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | metastasis | cervical lymph node | alive | 1.55 | Basal | European | TCGA.A2.A0YJ.01A.11R.A109.07 |
TCGA-S3-AA12 | 82 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | metastasis | lung|adrenal gland | alive | 1.57 | LumA | African | TCGA.S3.AA12.01A.11R.A41B.07 |
TCGA-A2-A0T6 | 50 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.57 | LumA | European | TCGA.A2.A0T6.01A.11R.A084.07 |
TCGA-D8-A1JE | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.57 | LumB | European | TCGA.D8.A1JE.01A.11R.A13Q.07 |
TCGA-EW-A1PA | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.57 | LumA | European | TCGA.EW.A1PA.01A.11R.A144.07 |
TCGA-E9-A1NH | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.58 | LumA | European | TCGA.E9.A1NH.01A.11R.A14D.07 |
TCGA-A8-A07F | 65 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.58 | LumA | European | TCGA.A8.A07F.01A.11R.A00Z.07 |
TCGA-A8-A07G | 65 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.58 | LumA | European | TCGA.A8.A07G.01A.11R.A034.07 |
TCGA-D8-A1JI | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.58 | LumB | European | TCGA.D8.A1JI.01A.11R.A13Q.07 |
TCGA-A8-A09T | 68 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.59 | LumA | European | TCGA.A8.A09T.01A.11R.A00Z.07 |
TCGA-A8-A0A2 | 66 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.59 | LumA | European | TCGA.A8.A0A2.01A.11R.A034.07 |
TCGA-A8-A07C | 57 | female | not available | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.59 | NA | European | TCGA.A8.A07C.01A.11R.A034.07 |
TCGA-A8-A08S | 71 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.59 | NA | European | TCGA.A8.A08S.01A.11R.A034.07 |
TCGA-A8-A091 | 61 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | not available | NA | alive | 1.59 | LumA | European | TCGA.A8.A091.01A.11R.A00Z.07 |
TCGA-A1-A0SP | 40 | female | not available | Primary solid Tumor | not available | IDC | negative | negative | negative | NA | NA | alive | 1.6 | Basal | European | TCGA.A1.A0SP.01A.11R.A084.07 |
TCGA-D8-A147 | 45 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | negative | NA | NA | alive | 1.6 | Basal | European | TCGA.D8.A147.01A.11R.A115.07 |
TCGA-AC-A23C | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.6 | LumA | European | TCGA.AC.A23C.01A.12R.A169.07 |
TCGA-S3-AA10 | 65 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.6 | Basal | African | TCGA.S3.AA10.01A.21R.A41B.07 |
TCGA-A2-A0YK | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.61 | Normal | European | TCGA.A2.A0YK.01A.22R.A109.07 |
TCGA-AC-A2QI | 76 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.61 | NA | European | TCGA.AC.A2QI.01A.12R.A19W.07 |
TCGA-AC-A5XS | 74 | female | White | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 1.61 | LumA | European | TCGA.AC.A5XS.01A.11R.A29R.07 |
TCGA-D8-A1JM | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.62 | Basal | European | TCGA.D8.A1JM.01A.11R.A13Q.07 |
TCGA-E2-A154 | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.62 | LumA | European | TCGA.E2.A154.01A.11R.A115.07 |
TCGA-LL-A7SZ | 49 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.63 | LumA | African | TCGA.LL.A7SZ.01A.32R.A352.07 |
TCGA-A2-A1G4 | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.63 | LumB | European | TCGA.A2.A1G4.01A.11R.A13Q.07 |
TCGA-E2-A15P | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.63 | LumA | European | TCGA.E2.A15P.01A.11R.A115.07 |
TCGA-LL-A8F5 | 61 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.63 | Basal | African | TCGA.LL.A8F5.01A.11R.A36F.07 |
TCGA-E2-A1L9 | 40 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.64 | LumA | European | TCGA.E2.A1L9.01A.11R.A13Q.07 |
TCGA-A8-A08G | 41 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.66 | LumB | European | TCGA.A8.A08G.01A.11R.A00Z.07 |
TCGA-EW-A1PH | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.66 | Basal | European | TCGA.EW.A1PH.01A.11R.A14M.07 |
TCGA-A8-A07E | 81 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.66 | LumA | European | TCGA.A8.A07E.01A.11R.A034.07 |
TCGA-EW-A1PB | 70 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.66 | Basal | African | TCGA.EW.A1PB.01A.11R.A144.07 |
TCGA-D8-A1JJ | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.67 | LumB | European | TCGA.D8.A1JJ.01A.31R.A14M.07 |
TCGA-D8-A1JL | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.67 | Basal | European | TCGA.D8.A1JL.01A.11R.A13Q.07 |
TCGA-BH-A2L8 | 45 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.68 | LumA | European | TCGA.BH.A2L8.01A.11R.A18M.07 |
TCGA-AR-A1AY | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.68 | Basal | European | TCGA.AR.A1AY.01A.21R.A12P.07 |
TCGA-AO-A0J7 | 71 | female | White | Primary solid Tumor | postmenopausal | ductal/mucinous | positive | positive | negative | NA | NA | alive | 1.69 | NA | European | TCGA.AO.A0J7.01A.11R.A034.07 |
TCGA-BH-A0HI | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.7 | LumA | European | TCGA.BH.A0HI.01A.11R.A084.07 |
TCGA-AO-A1KO | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.7 | Normal | European | TCGA.AO.A1KO.01A.31R.A13Q.07 |
TCGA-BH-A0AW | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.7 | Her2 | European | TCGA.BH.A0AW.01A.11R.A056.07 |
TCGA-D8-A141 | 40 | female | White | Primary solid Tumor | indeterminate | IDC | positive | positive | negative | NA | NA | alive | 1.71 | LumA | European | TCGA.D8.A141.01A.11R.A115.07 |
TCGA-E9-A22H | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.72 | LumB | European_admix | TCGA.E9.A22H.01A.11R.A157.07 |
TCGA-A2-A0T7 | 51 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.73 | LumA | European | TCGA.A2.A0T7.01A.21R.A084.07 |
TCGA-A1-A0SI | 52 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 1.74 | LumB | European | TCGA.A1.A0SI.01A.11R.A144.07 |
TCGA-BH-A42V | 41 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.74 | LumA | African | TCGA.BH.A42V.01A.11R.A24H.07 |
TCGA-D8-A13Z | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.74 | Her2 | European | TCGA.D8.A13Z.01A.11R.A115.07 |
TCGA-D8-A1JP | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.75 | LumA | European | TCGA.D8.A1JP.01A.11R.A13Q.07 |
TCGA-A8-A0A6 | 64 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.75 | LumA | European | TCGA.A8.A0A6.01A.12R.A056.07 |
TCGA-E2-A155 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.75 | LumB | European | TCGA.E2.A155.01A.11R.A12D.07 |
TCGA-A2-A0D0 | 60 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.76 | Basal | African | TCGA.A2.A0D0.01A.11R.A00Z.07 |
TCGA-A2-A4S2 | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.76 | LumA | European | TCGA.A2.A4S2.01A.12R.A266.07 |
TCGA-D8-A146 | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.76 | NA | European | TCGA.D8.A146.01A.31R.A115.07 |
TCGA-A7-A4SE | 54 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.76 | Basal | African | TCGA.A7.A4SE.01A.11R.A266.07 |
TCGA-LD-A66U | 44 | female | White | Primary solid Tumor | not evaluated | ILC | positive | positive | negative | NA | NA | alive | 1.77 | LumA | European | TCGA.LD.A66U.01A.11R.A31O.07 |
TCGA-EW-A3E8 | 60 | female | White | Primary solid Tumor | not evaluated | ILC | positive | negative | negative | NA | NA | alive | 1.77 | NA | European | TCGA.EW.A3E8.01B.11R.A24H.07 |
TCGA-A2-A4RY | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.77 | NA | European | TCGA.A2.A4RY.01A.31R.A266.07 |
TCGA-AO-A0JF | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.78 | LumA | European | TCGA.AO.A0JF.01A.11R.A056.07 |
TCGA-BH-A18H | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.79 | LumA | European | TCGA.BH.A18H.01A.11R.A12D.07 |
TCGA-E9-A1NA | 58 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 1.79 | NA | European | TCGA.E9.A1NA.01A.11R.A144.07 |
TCGA-E9-A1NA | 58 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 1.79 | NA | European | TCGA.E9.A1NA.11A.33R.A144.07 |
TCGA-AO-A0JA | 36 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | metastasis | bone | alive | 1.79 | LumA | African_admix | TCGA.AO.A0JA.01A.11R.A056.07 |
TCGA-E2-A15F | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.8 | LumA | European | TCGA.E2.A15F.01A.11R.A115.07 |
TCGA-A2-A0YH | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.8 | LumB | European | TCGA.A2.A0YH.01A.11R.A109.07 |
TCGA-D8-A4Z1 | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.8 | LumA | European | TCGA.D8.A4Z1.01A.21R.A266.07 |
TCGA-BH-A0BJ | 41 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.81 | LumA | European | TCGA.BH.A0BJ.01A.11R.A056.07 |
TCGA-BH-A0BJ | 41 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.81 | LumA | European | TCGA.BH.A0BJ.11A.23R.A089.07 |
TCGA-BH-A8G0 | 54 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.81 | LumA | European | TCGA.BH.A8G0.01A.11R.A352.07 |
TCGA-D8-A1XJ | 76 | female | White | Primary solid Tumor | postmenopausal | ductal/mucinous | positive | positive | positive | NA | NA | alive | 1.82 | NA | European | TCGA.D8.A1XJ.01A.11R.A14M.07 |
TCGA-AQ-A54O | 51 | male | Black or African American | Primary solid Tumor | not applicable | IDC | positive | positive | negative | NA | NA | alive | 1.82 | NA | African | TCGA.AQ.A54O.01A.11R.A266.07 |
TCGA-A2-A0YG | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.82 | LumB | European | TCGA.A2.A0YG.01A.21R.A109.07 |
TCGA-A2-A4S3 | 59 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.82 | LumB | African_admix | TCGA.A2.A4S3.01A.21R.A266.07 |
TCGA-A2-A04U | 47 | female | White | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.84 | Basal | European | TCGA.A2.A04U.01A.11R.A115.07 |
TCGA-E2-A1IN | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.85 | LumA | European | TCGA.E2.A1IN.01A.11R.A13Q.07 |
TCGA-AC-A2B8 | 84 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | new primary | rectum | alive | 1.85 | LumA | European | TCGA.AC.A2B8.01A.11R.A17B.07 |
TCGA-A7-A2KD | 53 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.86 | LumB | African | TCGA.A7.A2KD.01A.31R.A21T.07 |
TCGA-AO-A0J8 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.86 | LumA | European | TCGA.AO.A0J8.01A.21R.A034.07 |
TCGA-A2-A1FZ | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.87 | LumA | European | TCGA.A2.A1FZ.01A.51R.A14D.07 |
TCGA-E2-A1IK | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.89 | LumA | European | TCGA.E2.A1IK.01A.11R.A144.07 |
TCGA-E9-A22B | 71 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | negative | negative | NA | NA | alive | 1.89 | NA | European | TCGA.E9.A22B.01A.11R.A157.07 |
TCGA-EW-A1OW | 58 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.9 | NA | African | TCGA.EW.A1OW.01A.21R.A144.07 |
TCGA-BH-A0WA | 82 | female | White | Primary solid Tumor | not available | not available | negative | negative | negative | NA | NA | alive | 1.92 | NA | European | TCGA.BH.A0WA.01A.11R.A109.07 |
TCGA-A8-A08B | 52 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.92 | Her2 | European | TCGA.A8.A08B.01A.11R.A00Z.07 |
TCGA-BH-A0H7 | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.92 | LumA | European | TCGA.BH.A0H7.01A.13R.A056.07 |
TCGA-BH-A0H7 | 65 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.92 | LumA | European | TCGA.BH.A0H7.11A.13R.A089.07 |
TCGA-EW-A1P5 | 77 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.92 | LumA | European | TCGA.EW.A1P5.01A.11R.A144.07 |
TCGA-A2-A4S0 | 77 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 1.93 | NA | European | TCGA.A2.A4S0.01A.21R.A266.07 |
TCGA-AC-A3YI | 74 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.94 | Normal | European | TCGA.AC.A3YI.01A.21R.A239.07 |
TCGA-E2-A153 | 51 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.94 | LumA | European | TCGA.E2.A153.01A.12R.A12D.07 |
TCGA-E2-A153 | 51 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.94 | LumA | European | TCGA.E2.A153.11A.31R.A12D.07 |
TCGA-E9-A1NC | 61 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | negative | positive | positive | NA | NA | alive | 1.94 | NA | European | TCGA.E9.A1NC.01A.21R.A26B.07 |
TCGA-AR-A0TU | 35 | female | not available | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.94 | NA | European | TCGA.AR.A0TU.01A.31R.A109.07 |
TCGA-E2-A15A | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.94 | LumB | European | TCGA.E2.A15A.01A.11R.A12D.07 |
TCGA-GI-A2C9 | 58 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.95 | NA | African | TCGA.GI.A2C9.01A.11R.A21T.07 |
TCGA-GI-A2C9 | 58 | female | Black or African American | Solid Tissue Normal | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.95 | NA | African | TCGA.GI.A2C9.11A.22R.A21T.07 |
TCGA-BH-A0DG | 30 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.95 | LumA | African | TCGA.BH.A0DG.01A.21R.A12P.07 |
TCGA-BH-A0DG | 30 | female | Black or African American | Solid Tissue Normal | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.95 | LumA | African | TCGA.BH.A0DG.11A.43R.A12P.07 |
TCGA-E9-A22A | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.95 | LumB | European | TCGA.E9.A22A.01A.11R.A157.07 |
TCGA-A2-A1FV | 74 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.95 | LumA | European | TCGA.A2.A1FV.01A.11R.A13Q.07 |
TCGA-BH-A5J0 | 63 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.96 | LumA | African | TCGA.BH.A5J0.01A.11R.A27Q.07 |
TCGA-E9-A22G | 47 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.96 | Basal | European | TCGA.E9.A22G.01A.11R.A157.07 |
TCGA-A7-A26G | 50 | female | Black or African American | Primary solid Tumor | premenopausal | IDC with Metaplastic features (area of sarcomatoid carcinoma) | negative | negative | negative | NA | NA | alive | 1.98 | NA | African | TCGA.A7.A26G.01A.21R.A169.07 |
TCGA-E9-A54Y | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.98 | LumB | European | TCGA.E9.A54Y.01A.11R.A466.07 |
TCGA-E2-A156 | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.99 | LumA | European | TCGA.E2.A156.01A.11R.A12D.07 |
TCGA-BH-A0HF | 77 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.99 | NA | European | TCGA.BH.A0HF.01A.11R.A056.07 |
TCGA-E9-A54X | 85 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 1.99 | NA | European | TCGA.E9.A54X.01A.11R.A266.07 |
TCGA-A2-A0EU | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.01 | LumA | European | TCGA.A2.A0EU.01A.22R.A056.07 |
TCGA-AC-A3QQ | 54 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | positive | positive | NA | NA | alive | 2.01 | LumA | European | TCGA.AC.A3QQ.01A.11R.A22K.07 |
TCGA-A2-A4RX | 67 | female | Black or African American | Primary solid Tumor | postmenopausal | metaplastic carcinoma | positive | positive | negative | NA | NA | alive | 2.03 | NA | African | TCGA.A2.A4RX.01A.11R.A266.07 |
TCGA-BH-A0EI | 51 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.03 | LumA | European | TCGA.BH.A0EI.01A.11R.A115.07 |
TCGA-GM-A3NY | 72 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.03 | NA | European | TCGA.GM.A3NY.01A.11R.A21T.07 |
TCGA-BH-A0AU | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.04 | LumB | European | TCGA.BH.A0AU.01A.11R.A12P.07 |
TCGA-BH-A0AU | 45 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.04 | LumB | European | TCGA.BH.A0AU.11A.11R.A12P.07 |
TCGA-BH-A0H6 | 82 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.05 | LumA | European | TCGA.BH.A0H6.01A.21R.A056.07 |
TCGA-C8-A27A | 48 | female | Asian | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.05 | LumB | East Asian | TCGA.C8.A27A.01A.11R.A169.07 |
TCGA-E2-A14V | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.05 | Her2 | European | TCGA.E2.A14V.01A.11R.A12D.07 |
TCGA-A2-A0EX | 46 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.06 | LumA | European | TCGA.A2.A0EX.01A.21R.A034.07 |
TCGA-BH-A0BG | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.07 | Basal | European | TCGA.BH.A0BG.01A.11R.A115.07 |
TCGA-BH-A0W4 | 46 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 2.08 | LumA | European | TCGA.BH.A0W4.01A.11R.A109.07 |
TCGA-A8-A07U | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 2.08 | Basal | European | TCGA.A8.A07U.01A.11R.A034.07 |
TCGA-EW-A6SB | 62 | female | Black or African American | Primary solid Tumor | not available | IDC | negative | negative | negative | NA | NA | alive | 2.08 | Basal | African | TCGA.EW.A6SB.01A.12R.A32P.07 |
TCGA-A2-A0D2 | 45 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.08 | Basal | European | TCGA.A2.A0D2.01A.21R.A034.07 |
TCGA-A8-A09Q | 83 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.08 | LumB | European | TCGA.A8.A09Q.01A.11R.A00Z.07 |
TCGA-A2-A04Y | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.09 | LumB | European | TCGA.A2.A04Y.01A.21R.A034.07 |
TCGA-A2-A0D4 | 37 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.1 | LumB | African_admix | TCGA.A2.A0D4.01A.11R.A00Z.07 |
TCGA-D8-A73X | 53 | female | White | Primary solid Tumor | postmenopausal | tubular carcinoma | positive | positive | negative | NA | NA | alive | 2.1 | NA | European | TCGA.D8.A73X.01A.11R.A32P.07 |
TCGA-E2-A150 | 48 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.12 | Basal | European | TCGA.E2.A150.01A.11R.A12D.07 |
TCGA-AO-A0J6 | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.12 | Basal | European | TCGA.AO.A0J6.01A.11R.A034.07 |
TCGA-BH-A0AY | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.13 | LumA | European | TCGA.BH.A0AY.01A.21R.A00Z.07 |
TCGA-BH-A0AY | 62 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.13 | LumA | European | TCGA.BH.A0AY.11A.23R.A089.07 |
TCGA-A2-A0D1 | 76 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.15 | Her2 | European | TCGA.A2.A0D1.01A.11R.A034.07 |
TCGA-EW-A2FV | 39 | female | White | Primary solid Tumor | premenopausal | invasive micropapillary ductal carcinoma | positive | positive | negative | NA | NA | alive | 2.16 | NA | European | TCGA.EW.A2FV.01A.11R.A17B.07 |
TCGA-EW-A1OV | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.16 | Her2 | European | TCGA.EW.A1OV.01A.11R.A144.07 |
TCGA-A8-A06Y | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | not available | not available | alive | 2.17 | LumA | European | TCGA.A8.A06Y.01A.21R.A00Z.07 |
TCGA-BH-A202 | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.18 | LumB | European | TCGA.BH.A202.01A.11R.A14M.07 |
TCGA-AO-A0JG | 49 | female | White | Primary solid Tumor | postmenopausal | ductal/mucinous | positive | positive | negative | NA | NA | alive | 2.18 | NA | European | TCGA.AO.A0JG.01A.31R.A084.07 |
TCGA-A2-A3KD | 47 | female | White | Primary solid Tumor | premenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 2.2 | NA | European | TCGA.A2.A3KD.01A.12R.A213.07 |
TCGA-E9-A5FK | 60 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.22 | LumA | European | TCGA.E9.A5FK.01A.11R.A27Q.07 |
TCGA-AQ-A04J | 45 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.24 | Basal | European | TCGA.AQ.A04J.01A.02R.A034.07 |
TCGA-A2-A4S1 | 66 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | positive | negative | negative | NA | NA | alive | 2.25 | Basal | European | TCGA.A2.A4S1.01A.21R.A266.07 |
TCGA-A8-A0A9 | 80 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.25 | LumA | European | TCGA.A8.A0A9.01A.11R.A00Z.07 |
TCGA-E2-A152 | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | metastasis | liver>breast recur | alive | 2.26 | Her2 | European | TCGA.E2.A152.01A.11R.A12D.07 |
TCGA-BH-A0BQ | 39 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | locoregional recurrence | dermis|epidermis | alive | 2.26 | LumA | European | TCGA.BH.A0BQ.01A.21R.A115.07 |
TCGA-BH-A0BQ | 39 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | positive | locoregional recurrence | dermis|epidermis | alive | 2.26 | LumA | European | TCGA.BH.A0BQ.11A.33R.A115.07 |
TCGA-BH-A0HX | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.27 | LumA | European | TCGA.BH.A0HX.01A.21R.A056.07 |
TCGA-E2-A1L7 | 40 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | new primary | contralateral | alive | 2.28 | LumB | European | TCGA.E2.A1L7.01A.11R.A144.07 |
TCGA-E2-A1L7 | 40 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | new primary | contralateral | alive | 2.28 | LumB | European | TCGA.E2.A1L7.11A.33R.A144.07 |
TCGA-E2-A108 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.29 | Normal | European | TCGA.E2.A108.01A.13R.A10J.07 |
TCGA-E9-A1ND | 75 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.29 | Basal | European | TCGA.E9.A1ND.01A.11R.A144.07 |
TCGA-E9-A1ND | 75 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.29 | Basal | European | TCGA.E9.A1ND.11A.43R.A144.07 |
TCGA-AR-A2LR | 49 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | 2.32 | NA | European | TCGA.AR.A2LR.01A.12R.A18M.07 |
TCGA-OL-A6VR | 48 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | negative | NA | NA | alive | 2.32 | LumA | African_admix | TCGA.OL.A6VR.01A.32R.A33J.07 |
TCGA-E2-A1II | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 2.33 | Basal | European | TCGA.E2.A1II.01A.11R.A144.07 |
TCGA-A8-A07Z | 85 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.34 | LumA | European | TCGA.A8.A07Z.01A.11R.A00Z.07 |
TCGA-E2-A10C | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.34 | LumB | European | TCGA.E2.A10C.01A.21R.A10J.07 |
TCGA-BH-A201 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.34 | LumA | European | TCGA.BH.A201.01A.11R.A14M.07 |
TCGA-OL-A6VO | 43 | female | Black or African American | Primary solid Tumor | unknown | IDC | negative | negative | negative | NA | NA | alive | 2.35 | Basal | African_admix | TCGA.OL.A6VO.01A.12R.A33J.07 |
TCGA-A2-A3Y0 | 57 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 2.35 | Basal | African | TCGA.A2.A3Y0.01A.11R.A239.07 |
TCGA-AO-A12H | 69 | female | Black or African American | Primary solid Tumor | premenopausal | mucinous/papillary | positive | positive | negative | NA | NA | alive | 2.36 | NA | African | TCGA.AO.A12H.01A.11R.A115.07 |
TCGA-BH-A0AZ | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.37 | LumA | European | TCGA.BH.A0AZ.01A.21R.A12P.07 |
TCGA-BH-A0AZ | 47 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.37 | LumA | European | TCGA.BH.A0AZ.11A.22R.A12P.07 |
TCGA-BH-A0HY | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 2.38 | LumB | European | TCGA.BH.A0HY.01A.11R.A056.07 |
TCGA-A2-A0D3 | 42 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.4 | LumA | European | TCGA.A2.A0D3.01A.11R.A115.07 |
TCGA-A8-A08C | 65 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.41 | NA | European | TCGA.A8.A08C.01A.11R.A00Z.07 |
TCGA-WT-AB44 | 77 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.42 | LumA | European | TCGA.WT.AB44.01A.11R.A41B.07 |
TCGA-AO-A03V | 41 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.43 | LumA | European | TCGA.AO.A03V.01A.11R.A115.07 |
TCGA-AC-A4ZE | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 2.44 | LumA | European | TCGA.AC.A4ZE.01A.11R.A41B.07 |
TCGA-E2-A14T | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.44 | LumA | European | TCGA.E2.A14T.01A.11R.A115.07 |
TCGA-AR-A2LQ | 59 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.45 | Normal | European | TCGA.AR.A2LQ.01A.22R.A18M.07 |
TCGA-EW-A1OY | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.49 | LumB | European | TCGA.EW.A1OY.01A.11R.A144.07 |
TCGA-EW-A1OX | 43 | female | White | Primary solid Tumor | premenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 2.49 | NA | African_admix | TCGA.EW.A1OX.01A.11R.A144.07 |
TCGA-A8-A09K | 68 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.5 | NA | European | TCGA.A8.A09K.01A.11R.A00Z.07 |
TCGA-BH-A0DI | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.5 | LumA | European | TCGA.BH.A0DI.01A.21R.A12P.07 |
TCGA-E9-A22E | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.5 | LumB | European | TCGA.E9.A22E.01A.11R.A157.07 |
TCGA-BH-A0GY | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.53 | LumA | European | TCGA.BH.A0GY.01A.11R.A056.07 |
TCGA-E9-A3X8 | 48 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 2.54 | LumA | European | TCGA.E9.A3X8.01A.31R.A22U.07 |
TCGA-A7-A0CJ | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.55 | LumB | European | TCGA.A7.A0CJ.01A.21R.A00Z.07 |
TCGA-A8-A092 | 48 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.58 | LumB | European | TCGA.A8.A092.01A.11R.A00Z.07 |
TCGA-A8-A08O | 45 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | not available | not available | alive | 2.58 | LumA | European | TCGA.A8.A08O.01A.21R.A056.07 |
TCGA-A8-A08P | 70 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.58 | LumB | European | TCGA.A8.A08P.01A.11R.A00Z.07 |
TCGA-A8-A09E | 73 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.58 | NA | European | TCGA.A8.A09E.01A.11R.A00Z.07 |
TCGA-BH-A0EE | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.58 | Her2 | European | TCGA.BH.A0EE.01A.11R.A034.07 |
TCGA-BH-A0DE | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.6 | LumA | European | TCGA.BH.A0DE.01A.11R.A115.07 |
TCGA-EW-A6SC | 60 | female | Black or African American | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 2.61 | LumA | African | TCGA.EW.A6SC.01A.12R.A32P.07 |
TCGA-A7-A26E | 71 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.61 | LumA | European | TCGA.A7.A26E.01A.11R.A169.07 |
TCGA-E2-A1IF | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.62 | LumA | European | TCGA.E2.A1IF.01A.11R.A144.07 |
TCGA-A2-A0EV | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.65 | LumA | European | TCGA.A2.A0EV.01A.11R.A034.07 |
TCGA-E2-A14X | 55 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.66 | Basal | African_admix | TCGA.E2.A14X.01A.11R.A115.07 |
TCGA-E2-A1LB | 41 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.66 | Her2 | African | TCGA.E2.A1LB.01A.11R.A144.07 |
TCGA-E2-A1LB | 41 | female | Black or African American | Solid Tissue Normal | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.66 | Her2 | African | TCGA.E2.A1LB.11A.22R.A144.07 |
TCGA-A2-A3XZ | 46 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.66 | Her2 | African | TCGA.A2.A3XZ.01A.42R.A239.07 |
TCGA-BH-A0BC | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.67 | LumA | European | TCGA.BH.A0BC.01A.22R.A084.07 |
TCGA-BH-A0BC | 60 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.67 | LumA | European | TCGA.BH.A0BC.11A.22R.A089.07 |
TCGA-E2-A14Q | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.67 | LumA | European | TCGA.E2.A14Q.01A.11R.A12D.07 |
TCGA-A8-A07L | 58 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.67 | LumB | European | TCGA.A8.A07L.01A.11R.A00Z.07 |
TCGA-GM-A3XG | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.69 | NA | European | TCGA.GM.A3XG.01A.31R.A24H.07 |
TCGA-E2-A1B5 | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.69 | LumA | European | TCGA.E2.A1B5.01A.21R.A12P.07 |
TCGA-AC-A3BB | 46 | female | Black or African American | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 2.7 | NA | African | TCGA.AC.A3BB.01A.21R.A19W.07 |
TCGA-EW-A1P3 | 48 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.7 | LumA | European | TCGA.EW.A1P3.01A.11R.A144.07 |
TCGA-AQ-A1H3 | 49 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.71 | LumA | European | TCGA.AQ.A1H3.01A.31R.A13Q.07 |
TCGA-AR-A24W | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.71 | LumA | European | TCGA.AR.A24W.01A.11R.A169.07 |
TCGA-LL-A441 | 62 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.73 | NA | African | TCGA.LL.A441.01A.11R.A24H.07 |
TCGA-AR-A2LN | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.73 | LumA | European | TCGA.AR.A2LN.01A.21R.A18M.07 |
TCGA-E2-A1IG | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.73 | LumA | European | TCGA.E2.A1IG.01A.11R.A144.07 |
TCGA-E2-A1IG | 45 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.73 | LumA | European | TCGA.E2.A1IG.11A.22R.A144.07 |
TCGA-BH-A0HQ | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.07 | LumA | European | TCGA.BH.A0HQ.01A.11R.A034.07 |
TCGA-A8-A085 | 44 | male | not available | Primary solid Tumor | not applicable | IDC | positive | positive | negative | NA | NA | alive | 3.08 | NA | European | TCGA.A8.A085.01A.11R.A00Z.07 |
TCGA-BH-A0BA | 51 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 3.1 | NA | European | TCGA.BH.A0BA.01A.11R.A056.07 |
TCGA-BH-A0BA | 51 | female | White | Solid Tissue Normal | premenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 3.1 | NA | European | TCGA.BH.A0BA.11A.22R.A19E.07 |
TCGA-BH-A0B1 | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.14 | NA | European | TCGA.BH.A0B1.01A.12R.A056.07 |
TCGA-AR-A1AS | 54 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.15 | LumA | South Asian | TCGA.AR.A1AS.01A.11R.A12P.07 |
TCGA-BH-A0DH | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.16 | LumA | European | TCGA.BH.A0DH.01A.11R.A084.07 |
TCGA-BH-A0DH | 63 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.16 | LumA | European | TCGA.BH.A0DH.11A.31R.A089.07 |
TCGA-A8-A0AD | 83 | female | not available | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 3.17 | NA | European | TCGA.A8.A0AD.01A.11R.A056.07 |
TCGA-A1-A0SN | 50 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 3.27 | LumB | European | TCGA.A1.A0SN.01A.11R.A144.07 |
TCGA-BH-A0B3 | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 3.29 | Basal | European | TCGA.BH.A0B3.01A.11R.A056.07 |
TCGA-BH-A0B3 | 53 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 3.29 | Basal | European | TCGA.BH.A0B3.11B.21R.A089.07 |
TCGA-EW-A1IX | 48 | female | Asian | Primary solid Tumor | perimenopausal | invasive tubulolobular carcinoma | positive | positive | negative | NA | NA | alive | 3.31 | NA | East Asian | TCGA.EW.A1IX.01A.12R.A144.07 |
TCGA-A8-A08Z | 76 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.33 | LumA | European | TCGA.A8.A08Z.01A.21R.A00Z.07 |
TCGA-EW-A1P0 | 55 | female | White | Primary solid Tumor | postmenopausal | IDC/mucinous | positive | negative | negative | metastasis | mediastinal lymph node | alive | 3.43 | NA | European | TCGA.EW.A1P0.01A.11R.A144.07 |
TCGA-A8-A095 | 45 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.5 | LumB | European | TCGA.A8.A095.01A.11R.A00Z.07 |
TCGA-A8-A07B | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 3.58 | LumA | European | TCGA.A8.A07B.01A.11R.A00Z.07 |
TCGA-A8-A08X | 43 | female | not available | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | not available | not available | alive | 3.58 | Her2 | European | TCGA.A8.A08X.01A.21R.A00Z.07 |
TCGA-E2-A1LL | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | metastasis | liver | alive | 3.58 | Basal | African_admix | TCGA.E2.A1LL.01A.11R.A144.07 |
TCGA-A1-A0SE | 56 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 3.62 | NA | European | TCGA.A1.A0SE.01A.11R.A084.07 |
TCGA-B6-A1KC | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 3.63 | LumB | European | TCGA.B6.A1KC.01B.11R.A157.07 |
TCGA-BH-A0E7 | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.73 | LumA | European | TCGA.BH.A0E7.01A.11R.A034.07 |
TCGA-A8-A09I | 84 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 3.75 | LumB | European | TCGA.A8.A09I.01A.22R.A034.07 |
TCGA-E2-A14N | 37 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 3.93 | Basal | European | TCGA.E2.A14N.01A.31R.A137.07 |
TCGA-3C-AALK | 52 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | positive | NA | NA | alive | 3.96 | LumA | African | TCGA.3C.AALK.01A.11R.A41B.07 |
TCGA-A1-A0SF | 54 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.01 | LumA | European | TCGA.A1.A0SF.01A.11R.A144.07 |
TCGA-BH-A0BV | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.16 | LumA | European | TCGA.BH.A0BV.01A.11R.A00Z.07 |
TCGA-BH-A0BV | 78 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.16 | LumA | European | TCGA.BH.A0BV.11A.31R.A089.07 |
TCGA-AO-A0JI | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 4.18 | LumA | European | TCGA.AO.A0JI.01A.21R.A056.07 |
TCGA-A2-A0SX | 48 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 4.2 | Basal | European | TCGA.A2.A0SX.01A.12R.A084.07 |
TCGA-AO-A0JB | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.22 | Normal | European | TCGA.AO.A0JB.01A.11R.A32Y.07 |
TCGA-AO-A0JC | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.24 | LumA | European | TCGA.AO.A0JC.01A.11R.A056.07 |
TCGA-BH-A0B9 | 44 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 4.3 | Basal | European | TCGA.BH.A0B9.01A.11R.A056.07 |
TCGA-A2-A259 | 70 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.37 | LumA | African_admix | TCGA.A2.A259.01A.11R.A16F.07 |
TCGA-EW-A2FS | 41 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 4.39 | LumA | African | TCGA.EW.A2FS.01A.11R.A17B.07 |
TCGA-A8-A06T | 75 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 4.42 | LumA | European | TCGA.A8.A06T.01A.11R.A00Z.07 |
TCGA-A2-A0CZ | 46 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.42 | NA | European | TCGA.A2.A0CZ.01A.11R.A034.07 |
TCGA-E2-A1B0 | 50 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 4.47 | Her2 | European | TCGA.E2.A1B0.01A.11R.A12P.07 |
TCGA-AO-A12G | 75 | female | White | Primary solid Tumor | postmenopausal | pleomorphic ILC | positive | positive | positive | NA | NA | alive | 4.49 | NA | European | TCGA.AO.A12G.01A.11R.A10J.07 |
TCGA-A8-A076 | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 4.5 | LumB | European | TCGA.A8.A076.01A.21R.A00Z.07 |
TCGA-E2-A1L6 | 44 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.51 | LumA | European | TCGA.E2.A1L6.01A.11R.A13Q.07 |
TCGA-A2-A0SU | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.55 | LumA | European | TCGA.A2.A0SU.01A.11R.A084.07 |
TCGA-A2-A0CY | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.58 | NA | European | TCGA.A2.A0CY.01A.12R.A034.07 |
TCGA-AO-A0JL | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 4.61 | NA | European | TCGA.AO.A0JL.01A.11R.A056.07 |
TCGA-A2-A04X | 34 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 4.62 | Her2 | European | TCGA.A2.A04X.01A.21R.A034.07 |
TCGA-A2-A3XW | 42 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 4.69 | Normal | African_admix | TCGA.A2.A3XW.01A.11R.A239.07 |
TCGA-A2-A0CX | 52 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 4.73 | Her2 | European | TCGA.A2.A0CX.01A.21R.A00Z.07 |
TCGA-AO-A12F | 36 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 5.04 | Basal | European | TCGA.AO.A12F.01A.11R.A115.07 |
TCGA-AR-A1AV | 68 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | negative | NA | NA | alive | 5.1 | NA | European | TCGA.AR.A1AV.01A.21R.A12P.07 |
TCGA-AO-A03M | 29 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.11 | LumA | European | TCGA.AO.A03M.01B.11R.A10J.07 |
TCGA-BH-A0BM | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 5.14 | LumA | European | TCGA.BH.A0BM.01A.11R.A056.07 |
TCGA-BH-A0BM | 54 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 5.14 | LumA | European | TCGA.BH.A0BM.11A.12R.A089.07 |
TCGA-AO-A1KQ | 84 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | negative | NA | NA | alive | 5.15 | NA | European | TCGA.AO.A1KQ.01A.11R.A13Q.07 |
TCGA-AO-A0JJ | 54 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.17 | LumA | European | TCGA.AO.A0JJ.01A.11R.A056.07 |
TCGA-PE-A5DD | 64 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | negative | positive | NA | NA | alive | 5.35 | LumA | East Asian_admix | TCGA.PE.A5DD.01A.12R.A27Q.07 |
TCGA-AR-A0TX | 64 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 5.4 | Her2 | European | TCGA.AR.A0TX.01A.11R.A084.07 |
TCGA-GM-A3XN | 44 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.53 | NA | European | TCGA.GM.A3XN.01A.12R.A22U.07 |
TCGA-AO-A03N | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | locoregional disease | NA | alive | 5.56 | LumB | European | TCGA.AO.A03N.01B.11R.A10J.07 |
TCGA-BH-A0DV | 54 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.65 | LumA | European | TCGA.BH.A0DV.01A.21R.A12P.07 |
TCGA-BH-A0DV | 54 | female | White | Solid Tissue Normal | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.65 | LumA | European | TCGA.BH.A0DV.11A.22R.A12P.07 |
TCGA-AO-A03R | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.72 | Normal | European | TCGA.AO.A03R.01A.21R.A034.07 |
TCGA-AO-A03T | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.82 | Normal | European | TCGA.AO.A03T.01A.21R.A034.07 |
TCGA-BH-A0B5 | 40 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.85 | LumA | European | TCGA.BH.A0B5.01A.11R.A12P.07 |
TCGA-BH-A0B5 | 40 | female | White | Solid Tissue Normal | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.85 | LumA | European | TCGA.BH.A0B5.11A.23R.A12P.07 |
TCGA-AO-A12E | 51 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.86 | LumA | European | TCGA.AO.A12E.01A.11R.A10J.07 |
TCGA-GM-A2DF | 53 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 5.9 | Basal | African | TCGA.GM.A2DF.01A.11R.A180.07 |
TCGA-BH-A0DX | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.9 | LumA | European | TCGA.BH.A0DX.01A.11R.A115.07 |
TCGA-AR-A255 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 5.92 | LumA | European | TCGA.AR.A255.01A.11R.A169.07 |
TCGA-B6-A40C | 51 | female | White | Primary solid Tumor | unknown | ILC | positive | positive | negative | NA | NA | alive | 5.92 | LumA | European | TCGA.B6.A40C.01A.11R.A239.07 |
TCGA-A2-A0ES | 52 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 6.0 | LumA | European | TCGA.A2.A0ES.01A.11R.A115.07 |
TCGA-AO-A0JD | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.0 | LumB | European | TCGA.AO.A0JD.01A.11R.A056.07 |
TCGA-GM-A2DH | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.0 | Her2 | European | TCGA.GM.A2DH.01A.11R.A180.07 |
TCGA-BH-A0BO | 54 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.02 | LumA | European | TCGA.BH.A0BO.01A.23R.A12D.07 |
TCGA-AC-A2BK | 78 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.08 | Basal | African | TCGA.AC.A2BK.01A.11R.A21T.07 |
TCGA-AC-A2FO | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 6.17 | LumA | European | TCGA.AC.A2FO.01A.11R.A180.07 |
TCGA-BH-A0BZ | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.17 | LumB | European | TCGA.BH.A0BZ.01A.31R.A12P.07 |
TCGA-BH-A0BZ | 59 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.17 | LumB | European | TCGA.BH.A0BZ.11A.61R.A12P.07 |
TCGA-BH-A0BL | 35 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.24 | Basal | European | TCGA.BH.A0BL.01A.11R.A115.07 |
TCGA-B6-A402 | 47 | female | Black or African American | Primary solid Tumor | unknown | IDC | negative | negative | negative | locoregional recurrence | breast>lymph node | alive | 6.25 | NA | African | TCGA.B6.A402.01A.11R.A239.07 |
TCGA-BH-A0BR | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.38 | LumA | European | TCGA.BH.A0BR.01A.21R.A115.07 |
TCGA-AO-A0JE | 53 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 6.39 | Her2 | African | TCGA.AO.A0JE.01A.11R.A056.07 |
TCGA-BH-A0BT | 56 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 6.48 | LumA | European | TCGA.BH.A0BT.01A.11R.A12P.07 |
TCGA-BH-A0BT | 56 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | alive | 6.48 | LumA | European | TCGA.BH.A0BT.11A.21R.A12P.07 |
TCGA-AO-A12C | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 6.49 | NA | European | TCGA.AO.A12C.01A.11R.A10J.07 |
TCGA-BH-A0DL | 64 | female | White | Primary solid Tumor | postmenopausal | IDC with metaplastic carcinoma and focal apocrine features | positive | negative | negative | NA | NA | alive | 6.52 | NA | European | TCGA.BH.A0DL.01A.11R.A115.07 |
TCGA-BH-A0DL | 64 | female | White | Solid Tissue Normal | postmenopausal | IDC with metaplastic carcinoma and focal apocrine features | positive | negative | negative | NA | NA | alive | 6.52 | NA | European | TCGA.BH.A0DL.11A.13R.A115.07 |
TCGA-AR-A1AJ | 83 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 6.52 | Basal | European | TCGA.AR.A1AJ.01A.21R.A12P.07 |
TCGA-BH-A0DT | 41 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.58 | LumA | European | TCGA.BH.A0DT.01A.21R.A12D.07 |
TCGA-BH-A0DT | 41 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.58 | LumA | European | TCGA.BH.A0DT.11A.12R.A12D.07 |
TCGA-GM-A2DB | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.59 | Her2 | European | TCGA.GM.A2DB.01A.31R.A18M.07 |
TCGA-A2-A0EQ | 64 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 6.64 | Her2 | African | TCGA.A2.A0EQ.01A.11R.A034.07 |
TCGA-A2-A0EO | 54 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.69 | LumA | European | TCGA.A2.A0EO.01A.11R.A034.07 |
TCGA-AO-A03L | 34 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 6.69 | LumA | South Asian_admix | TCGA.AO.A03L.01A.41R.A056.07 |
TCGA-BH-A0B0 | 56 | female | Black or African American | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.78 | LumA | African_admix | TCGA.BH.A0B0.01A.21R.A115.07 |
TCGA-BH-A0B6 | 47 | female | White | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | alive | 6.8 | NA | European | TCGA.BH.A0B6.01A.11R.A19W.07 |
TCGA-BH-A0DD | 58 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | positive | NA | NA | alive | 6.81 | NA | European | TCGA.BH.A0DD.01A.31R.A12P.07 |
TCGA-BH-A0DD | 58 | male | White | Solid Tissue Normal | not applicable | IDC | positive | positive | positive | NA | NA | alive | 6.81 | NA | European | TCGA.BH.A0DD.11A.23R.A12P.07 |
TCGA-BH-A0E9 | 53 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 6.81 | LumA | European | TCGA.BH.A0E9.01B.11R.A115.07 |
TCGA-AO-A1KR | 51 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.88 | Basal | European | TCGA.AO.A1KR.01A.12R.A144.07 |
TCGA-AO-A12D | 43 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 6.89 | Her2 | European | TCGA.AO.A12D.01A.11R.A115.07 |
TCGA-AR-A0TS | 46 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 7.0 | Basal | European | TCGA.AR.A0TS.01A.11R.A115.07 |
TCGA-BH-A0B7 | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 7.01 | Her2 | European | TCGA.BH.A0B7.01A.12R.A115.07 |
TCGA-BH-A0B7 | 42 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 7.01 | Her2 | European | TCGA.BH.A0B7.11A.34R.A115.07 |
TCGA-B6-A401 | 47 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | negative | NA | NA | alive | 7.11 | LumA | African_admix | TCGA.B6.A401.01A.11R.A239.07 |
TCGA-GM-A2DO | 54 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 7.11 | LumB | African | TCGA.GM.A2DO.01A.11R.A18M.07 |
TCGA-AR-A254 | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 7.13 | Her2 | European | TCGA.AR.A254.01A.21R.A169.07 |
TCGA-AR-A1AO | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 7.17 | Normal | European | TCGA.AR.A1AO.01A.11R.A12P.07 |
TCGA-AR-A1AX | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 7.2 | LumA | European | TCGA.AR.A1AX.01A.11R.A12P.07 |
TCGA-AR-A2LJ | 40 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | positive | NA | NA | alive | 7.21 | NA | European | TCGA.AR.A2LJ.01A.12R.A19W.07 |
TCGA-GM-A2DK | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 7.24 | LumA | European | TCGA.GM.A2DK.01A.21R.A180.07 |
TCGA-PE-A5DE | 41 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 7.24 | LumA | European | TCGA.PE.A5DE.01A.11R.A27Q.07 |
TCGA-BH-A0C3 | 47 | female | White | Primary solid Tumor | premenopausal | with IDC/ILC phenotypes | positive | negative | negative | metastasis | bone | alive | 7.42 | NA | European | TCGA.BH.A0C3.01A.21R.A12P.07 |
TCGA-BH-A0C3 | 47 | female | White | Solid Tissue Normal | premenopausal | with IDC/ILC phenotypes | positive | negative | negative | metastasis | bone | alive | 7.42 | NA | European | TCGA.BH.A0C3.11A.23R.A12P.07 |
TCGA-A2-A3XT | 45 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 7.58 | Basal | African | TCGA.A2.A3XT.01A.11R.A22U.07 |
TCGA-AR-A252 | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 7.77 | LumA | European | TCGA.AR.A252.01A.11R.A169.07 |
TCGA-AR-A1AN | 46 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 7.99 | LumA | European | TCGA.AR.A1AN.01A.11R.A12P.07 |
TCGA-AO-A1KP | 77 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.08 | LumB | European | TCGA.AO.A1KP.01A.11R.A13Q.07 |
TCGA-AR-A1AL | 60 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.13 | LumA | European | TCGA.AR.A1AL.01A.21R.A12P.07 |
TCGA-AR-A24S | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.15 | LumB | European | TCGA.AR.A24S.01A.11R.A169.07 |
TCGA-AR-A24Z | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.22 | LumB | European | TCGA.AR.A24Z.01A.11R.A169.07 |
TCGA-A2-A0CV | 41 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.24 | LumA | East Asian | TCGA.A2.A0CV.01A.31R.A115.07 |
TCGA-A2-A0CL | 37 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.25 | Normal | African | TCGA.A2.A0CL.01A.11R.A115.07 |
TCGA-GM-A2DN | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.46 | LumA | European | TCGA.GM.A2DN.01A.11R.A180.07 |
TCGA-A2-A04W | 50 | female | White | Primary solid Tumor | premenopausal | apocrine | negative | negative | positive | NA | NA | alive | 8.49 | NA | European | TCGA.A2.A04W.01A.31R.A115.07 |
TCGA-AO-A12A | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.52 | LumA | European | TCGA.AO.A12A.01A.21R.A115.07 |
TCGA-AR-A24U | 47 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 8.56 | Her2 | European | TCGA.AR.A24U.01A.11R.A169.07 |
TCGA-B6-A40B | 76 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.63 | LumA | European | TCGA.B6.A40B.01A.11R.A239.07 |
TCGA-AR-A1AK | 70 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.65 | LumA | European | TCGA.AR.A1AK.01A.21R.A12P.07 |
TCGA-AR-A24Q | 49 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 8.68 | Basal | European | TCGA.AR.A24Q.01A.12R.A169.07 |
TCGA-AR-A24V | 52 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.77 | LumA | European | TCGA.AR.A24V.01A.21R.A169.07 |
TCGA-GM-A2DM | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.83 | LumA | American | TCGA.GM.A2DM.01A.11R.A180.07 |
TCGA-E2-A1LH | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 8.89 | Basal | European | TCGA.E2.A1LH.01A.11R.A14D.07 |
TCGA-E2-A1LH | 59 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 8.89 | Basal | European | TCGA.E2.A1LH.11A.22R.A14D.07 |
TCGA-AO-A128 | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 8.89 | Basal | European | TCGA.AO.A128.01A.11R.A10J.07 |
TCGA-Z7-A8R6 | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.91 | LumB | European | TCGA.Z7.A8R6.01A.11R.A41B.07 |
TCGA-AR-A0U4 | 54 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 8.93 | Basal | European | TCGA.AR.A0U4.01A.11R.A109.07 |
TCGA-A2-A0CR | 54 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.99 | LumA | East Asian | TCGA.A2.A0CR.01A.11R.A22K.07 |
TCGA-AO-A129 | 29 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 9.0 | Basal | European | TCGA.AO.A129.01A.21R.A10J.07 |
TCGA-Z7-A8R5 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | locoregional recurrence | recur>bone | alive | 9.0 | LumA | European | TCGA.Z7.A8R5.01A.42R.A41B.07 |
TCGA-AO-A126 | 39 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | locoregional recurrence | NA | alive | 9.05 | LumA | East Asian | TCGA.AO.A126.01A.11R.A10J.07 |
TCGA-AR-A0TT | 53 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 9.08 | LumB | African_admix | TCGA.AR.A0TT.01A.31R.A084.07 |
TCGA-BH-A42U | 80 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | NA | NA | alive | 9.21 | Normal | African | TCGA.BH.A42U.01A.12R.A24H.07 |
TCGA-AR-A24R | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 9.39 | LumB | European | TCGA.AR.A24R.01A.11R.A169.07 |
TCGA-AO-A125 | 72 | female | Black or African American | Primary solid Tumor | postmenopausal | papillary carcinoma | positive | positive | negative | NA | NA | alive | 9.46 | NA | African | TCGA.AO.A125.01A.11R.A10J.07 |
TCGA-AO-A124 | 38 | female | White | Primary solid Tumor | premenopausal | mucinous/ductal | negative | negative | negative | NA | NA | alive | 9.6 | NA | European | TCGA.AO.A124.01A.11R.A10J.07 |
TCGA-GM-A2DL | 50 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 9.63 | LumA | European | TCGA.GM.A2DL.01A.11R.A18M.07 |
TCGA-A2-A0EP | 56 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 9.86 | LumA | European | TCGA.A2.A0EP.01A.52R.A22U.07 |
TCGA-AR-A24O | 43 | female | White | Primary solid Tumor | premenopausal | ILC with ductal features | positive | positive | negative | not available | not available | alive | 9.88 | NA | European | TCGA.AR.A24O.01A.11R.A169.07 |
TCGA-AR-A24M | 38 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 10.02 | NA | European | TCGA.AR.A24M.01A.11R.A169.07 |
TCGA-AR-A1AH | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 10.42 | Basal | European | TCGA.AR.A1AH.01A.11R.A12D.07 |
TCGA-AQ-A04L | 48 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | negative | positive | NA | NA | alive | 10.83 | NA | European | TCGA.AQ.A04L.01B.21R.A10J.07 |
TCGA-3C-AALI | 50 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 10.97 | Her2 | African | TCGA.3C.AALI.01A.11R.A41B.07 |
TCGA-3C-AAAU | 55 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | metastasis | lung | alive | 11.08 | LumA | European | TCGA.3C.AAAU.01A.11R.A41B.07 |
TCGA-AR-A0U3 | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 11.17 | LumA | European | TCGA.AR.A0U3.01A.11R.A109.07 |
TCGA-A2-A0CK | 60 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | new primary | contralateral | alive | 11.39 | LumA | European | TCGA.A2.A0CK.01A.11R.A22K.07 |
TCGA-AR-A0TP | 43 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 11.7 | Basal | European | TCGA.AR.A0TP.01A.11R.A084.07 |
TCGA-AR-A24H | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 13.4 | LumB | European | TCGA.AR.A24H.01A.11R.A169.07 |
TCGA-AC-A23H | 90 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | dead | NA | Her2 | European | TCGA.AC.A23H.01A.11R.A157.07 |
TCGA-AC-A23H | 90 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | negative | positive | NA | NA | dead | NA | Her2 | European | TCGA.AC.A23H.11A.12R.A157.07 |
TCGA-E9-A1N6 | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | metastasis | bone>recur>liver | dead | NA | NA | European | TCGA.E9.A1N6.01A.11R.A144.07 |
TCGA-E9-A1N6 | 52 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | positive | metastasis | bone>recur>liver | dead | NA | NA | European | TCGA.E9.A1N6.11A.32R.A144.07 |
TCGA-E9-A1NG | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | NA | LumA | European | TCGA.E9.A1NG.01A.21R.A14M.07 |
TCGA-E9-A1NG | 62 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | NA | LumA | European | TCGA.E9.A1NG.11A.52R.A14M.07 |
TCGA-E9-A1NF | 60 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | dead | NA | NA | European | TCGA.E9.A1NF.01A.11R.A14D.07 |
TCGA-E9-A1NF | 60 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | dead | NA | NA | European | TCGA.E9.A1NF.11A.73R.A14D.07 |
TCGA-C8-A3M7 | 60 | female | Asian | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | locoregional recurrence | NA | dead | 0.0 | LumA | East Asian | TCGA.C8.A3M7.01A.12R.A21T.07 |
TCGA-C8-A12Q | 78 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | metastasis | liver | dead | 0.01 | Her2 | East Asian | TCGA.C8.A12Q.01A.11R.A115.07 |
TCGA-AC-A3EH | 79 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | dead | 0.05 | NA | European | TCGA.AC.A3EH.01A.22R.A22K.07 |
TCGA-A8-A08L | 89 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | dead | 0.08 | Her2 | European | TCGA.A8.A08L.01A.11R.A00Z.07 |
TCGA-BH-A42T | 75 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | dead | 0.88 | NA | African_admix | TCGA.BH.A42T.01A.11R.A24H.07 |
TCGA-AC-A2QJ | 48 | female | White | Primary solid Tumor | perimenopausal | metaplastic carcinoma | negative | negative | negative | metastasis | bone | dead | 1.22 | NA | American | TCGA.AC.A2QJ.01A.12R.A19W.07 |
TCGA-D8-A1XC | 85 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | metastasis | bone | dead | 1.03 | NA | European | TCGA.D8.A1XC.01A.11R.A14D.07 |
TCGA-D8-A1Y1 | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 0.83 | LumB | European | TCGA.D8.A1Y1.01A.21R.A14M.07 |
TCGA-E2-A15M | 66 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 0.92 | LumA | European | TCGA.E2.A15M.01A.11R.A12D.07 |
TCGA-E2-A15M | 66 | female | White | Solid Tissue Normal | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 0.92 | LumA | European | TCGA.E2.A15M.11A.22R.A12D.07 |
TCGA-D8-A73W | 79 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | negative | negative | metastasis | lung|bone | dead | 1.05 | NA | European | TCGA.D8.A73W.01A.22R.A352.07 |
TCGA-A2-A0T2 | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | metastasis | liver|abdomen | dead | 0.7 | Basal | European | TCGA.A2.A0T2.01A.11R.A084.07 |
TCGA-AQ-A7U7 | 55 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 1.6 | LumA | European | TCGA.AQ.A7U7.01A.22R.A352.07 |
TCGA-E2-A14Z | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | metastasis | bone | dead | 1.54 | LumA | European | TCGA.E2.A14Z.01A.11R.A115.07 |
TCGA-A2-A0CM | 40 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | dead | 2.06 | Basal | African_admix | TCGA.A2.A0CM.01A.31R.A034.07 |
TCGA-A2-A0EW | 53 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | metastasis | bone | dead | 5.16 | LumA | European | TCGA.A2.A0EW.01A.21R.A115.07 |
TCGA-BH-A0BF | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 3.62 | LumB | European | TCGA.BH.A0BF.01A.21R.A12P.07 |
TCGA-A2-A3XY | 49 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | metastasis | lung>lymph nodes>brain | dead | 2.99 | NA | African | TCGA.A2.A3XY.01A.11R.A239.07 |
TCGA-A8-A06U | 80 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 2.42 | LumA | European | TCGA.A8.A06U.01A.11R.A00Z.07 |
TCGA-E2-A1B4 | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 2.75 | LumA | European | TCGA.E2.A1B4.01A.11R.A12P.07 |
TCGA-A8-A06X | 77 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | dead | 2.58 | LumB | European | TCGA.A8.A06X.01A.21R.A00Z.07 |
TCGA-A1-A0SK | 54 | female | Asian | Primary solid Tumor | indeterminate | \neuroendocrine carcinoma, large-cell type, high-grade\"" | negative | negative | negative | NA | NA | dead | 2.65 | NA | East Asian | TCGA.A1.A0SK.01A.12R.A084.07 |
TCGA-A8-A08J | 52 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | dead | 3.09 | Her2 | European | TCGA.A8.A08J.01A.11R.A00Z.07 |
TCGA-B6-A3ZX | 50 | female | Black or African American | Primary solid Tumor | unknown | IDC/ILC | negative | negative | negative | metastasis | bone | dead | 3.15 | NA | African | TCGA.B6.A3ZX.01A.11R.A239.07 |
TCGA-A2-A3XX | 49 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | dead | 3.94 | Basal | African | TCGA.A2.A3XX.01A.21R.A239.07 |
TCGA-BH-A0C1 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | metastasis | bone | dead | 3.86 | LumA | European | TCGA.BH.A0C1.01B.11R.A12D.07 |
TCGA-A2-A0CO | 85 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 4.02 | NA | European | TCGA.A2.A0CO.01A.13R.A22K.07 |
TCGA-BH-A0BP | 76 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 6.29 | LumA | European | TCGA.BH.A0BP.01A.11R.A115.07 |
TCGA-HN-A2OB | 45 | female | not available | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | metastasis | bone|omentum | dead | 5.2 | LumA | European | TCGA.HN.A2OB.01A.21R.A27Q.07 |
TCGA-AO-A03P | 54 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | metastasis | liver | dead | 7.97 | LumB | African | TCGA.AO.A03P.01A.11R.A00Z.07 |
TCGA-A8-A08T | 64 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | not available | not available | dead | 9.33 | LumA | European | TCGA.A8.A08T.01A.21R.A00Z.07 |
TCGA-BH-A1F8 | 90 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | NA | LumB | European | TCGA.BH.A1F8.01A.11R.A13Q.07 |
TCGA-BH-A1F8 | 90 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | NA | LumB | European | TCGA.BH.A1F8.11B.21R.A13Q.07 |
TCGA-UU-A93S | 63 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | metastasis | bone|liver | dead | 0.32 | Her2 | African_admix | TCGA.UU.A93S.01A.21R.A41B.07 |
TCGA-AQ-A0Y5 | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 0.47 | LumA | European | TCGA.AQ.A0Y5.01A.11R.A14M.07 |
TCGA-BH-A18T | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | dead | 0.61 | Basal | European | TCGA.BH.A18T.01A.11R.A12D.07 |
TCGA-EW-A1P8 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | metastasis | lung|bone|liver|skin | dead | 0.65 | Basal | European | TCGA.EW.A1P8.01A.11R.A144.07 |
TCGA-BH-A8FY | 87 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 0.81 | LumA | European | TCGA.BH.A8FY.01A.11R.A36F.07 |
TCGA-AR-A5QQ | 68 | female | White | Primary solid Tumor | postmenopausal | squamous (metaplastic) carcinoma | negative | negative | negative | locoregional recurrence | chest wall|lung|liver|bone|adrenal glands | dead | 0.88 | NA | European | TCGA.AR.A5QQ.01A.11R.A28M.07 |
TCGA-BH-A1EV | 45 | female | White | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | dead | 1.0 | Her2 | European | TCGA.BH.A1EV.01A.11R.A137.07 |
TCGA-BH-A1EV | 45 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | positive | NA | NA | dead | 1.0 | Her2 | European | TCGA.BH.A1EV.11A.24R.A137.07 |
TCGA-A8-A09X | 62 | female | not available | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | NA | NA | dead | 1.17 | Her2 | European | TCGA.A8.A09X.01A.11R.A00Z.07 |
TCGA-BH-A18N | 88 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 1.28 | LumA | European | TCGA.BH.A18N.01A.11R.A12D.07 |
TCGA-BH-A18N | 88 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | dead | 1.28 | LumA | European | TCGA.BH.A18N.11A.43R.A12D.07 |
TCGA-AR-A1AR | 50 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | new primary | contralateral | dead | 1.43 | Basal | European | TCGA.AR.A1AR.01A.31R.A137.07 |
TCGA-BH-A1EY | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | metastasis | lung|liver | dead | 1.47 | LumA | European | TCGA.BH.A1EY.01A.11R.A13Q.07 |
TCGA-BH-A1FG | 88 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 1.58 | LumA | European | TCGA.BH.A1FG.01A.11R.A13Q.07 |
TCGA-BH-A1FG | 88 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 1.58 | LumA | European | TCGA.BH.A1FG.11B.12R.A13Q.07 |
TCGA-BH-A18J | 56 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | metastasis | bone | dead | 1.68 | LumA | European | TCGA.BH.A18J.01A.11R.A12D.07 |
TCGA-BH-A18J | 56 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | metastasis | bone | dead | 1.68 | LumA | European | TCGA.BH.A18J.11A.31R.A12D.07 |
TCGA-BH-A18L | 50 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 2.22 | LumB | European | TCGA.BH.A18L.01A.32R.A12D.07 |
TCGA-BH-A18L | 50 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | dead | 2.22 | LumB | European | TCGA.BH.A18L.11A.42R.A12D.07 |
TCGA-E2-A1LE | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | metastasis | lung | dead | 2.41 | NA | European | TCGA.E2.A1LE.01A.12R.A19W.07 |
TCGA-BH-A18P | 60 | female | White | Primary solid Tumor | not available | IDC | positive | negative | positive | NA | NA | dead | 2.52 | Her2 | European | TCGA.BH.A18P.01A.11R.A12D.07 |
TCGA-BH-A18P | 60 | female | White | Solid Tissue Normal | not available | IDC | positive | negative | positive | NA | NA | dead | 2.52 | Her2 | European | TCGA.BH.A18P.11A.43R.A12D.07 |
TCGA-BH-A1F2 | 53 | female | White | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | dead | 2.63 | LumB | European | TCGA.BH.A1F2.01A.31R.A13Q.07 |
TCGA-BH-A1F2 | 53 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | positive | NA | NA | dead | 2.63 | LumB | European | TCGA.BH.A1F2.11A.32R.A13Q.07 |
TCGA-BH-A0EA | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 2.71 | LumA | European | TCGA.BH.A0EA.01A.11R.A115.07 |
TCGA-BH-A1FD | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 2.76 | LumB | European | TCGA.BH.A1FD.01A.11R.A13Q.07 |
TCGA-BH-A1FD | 68 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 2.76 | LumB | European | TCGA.BH.A1FD.11B.21R.A13Q.07 |
TCGA-AR-A1AT | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | dead | 3.48 | NA | European | TCGA.AR.A1AT.01A.11R.A12P.07 |
TCGA-BH-A1EU | 83 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 3.52 | LumA | European | TCGA.BH.A1EU.01A.11R.A137.07 |
TCGA-BH-A1EU | 83 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 3.52 | LumA | European | TCGA.BH.A1EU.11A.23R.A137.07 |
TCGA-PE-A5DC | 72 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | dead | 3.92 | LumA | European | TCGA.PE.A5DC.01A.12R.A27Q.07 |
TCGA-BH-A1EX | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 4.13 | LumA | East Asian | TCGA.BH.A1EX.01A.11R.A13Q.07 |
TCGA-BH-A18U | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 4.28 | LumB | European | TCGA.BH.A18U.01A.21R.A12D.07 |
TCGA-BH-A18U | 72 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 4.28 | LumB | European | TCGA.BH.A18U.11A.23R.A12D.07 |
TCGA-BH-A18Q | 56 | female | White | Primary solid Tumor | not available | IDC | negative | negative | positive | NA | NA | dead | 4.63 | Basal | European | TCGA.BH.A18Q.01A.12R.A12D.07 |
TCGA-BH-A18Q | 56 | female | White | Solid Tissue Normal | not available | IDC | negative | negative | positive | NA | NA | dead | 4.63 | Basal | European | TCGA.BH.A18Q.11A.34R.A12D.07 |
TCGA-BH-A1EW | 38 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | dead | 4.64 | LumA | European | TCGA.BH.A1EW.01A.11R.A137.07 |
TCGA-BH-A1EW | 38 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | dead | 4.64 | LumA | European | TCGA.BH.A1EW.11B.33R.A137.07 |
TCGA-AR-A0TY | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | metastasis | bone | dead | 4.65 | LumB | European | TCGA.AR.A0TY.01A.12R.A115.07 |
TCGA-AO-A03U | 31 | female | White | Primary solid Tumor | premenopausal | secretory | negative | negative | negative | NA | NA | dead | 4.91 | NA | European | TCGA.AO.A03U.01B.21R.A10J.07 |
TCGA-BH-A18S | 79 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | dead | 5.5 | NA | European | TCGA.BH.A18S.01A.11R.A12D.07 |
TCGA-BH-A18S | 79 | female | White | Solid Tissue Normal | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | dead | 5.5 | NA | European | TCGA.BH.A18S.11A.43R.A12D.07 |
TCGA-BH-A1EN | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | dead | 5.82 | Her2 | European | TCGA.BH.A1EN.01A.11R.A13Q.07 |
TCGA-BH-A1EN | 78 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | negative | positive | NA | NA | dead | 5.82 | Her2 | European | TCGA.BH.A1EN.11A.23R.A13Q.07 |
TCGA-BH-A18M | 39 | female | White | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | dead | 6.04 | LumA | European | TCGA.BH.A18M.01A.11R.A12D.07 |
TCGA-BH-A18M | 39 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | positive | NA | NA | dead | 6.04 | LumA | European | TCGA.BH.A18M.11A.33R.A12D.07 |
TCGA-AO-A03O | 69 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 6.8 | LumB | African_admix | TCGA.AO.A03O.01A.11R.A00Z.07 |
TCGA-BH-A1ET | 55 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 6.9 | LumA | European | TCGA.BH.A1ET.01A.11R.A137.07 |
TCGA-BH-A1ET | 55 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | dead | 6.9 | LumA | European | TCGA.BH.A1ET.11B.23R.A137.07 |
TCGA-AR-A0U2 | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | metastasis | bone|liver | dead | 6.98 | LumB | European | TCGA.AR.A0U2.01A.11R.A109.07 |
TCGA-BH-A1F5 | 62 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 7.43 | NA | European | TCGA.BH.A1F5.01A.12R.A13Q.07 |
TCGA-BH-A18K | 46 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 7.56 | LumA | European | TCGA.BH.A18K.01A.11R.A12D.07 |
TCGA-BH-A18K | 46 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | dead | 7.56 | LumA | European | TCGA.BH.A18K.11A.13R.A12D.07 |
TCGA-BH-A1EO | 68 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC features | positive | positive | negative | NA | NA | dead | 7.66 | NA | European | TCGA.BH.A1EO.01A.11R.A137.07 |
TCGA-BH-A1EO | 68 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC features | positive | positive | negative | NA | NA | dead | 7.66 | NA | European | TCGA.BH.A1EO.11A.31R.A137.07 |
TCGA-AR-A256 | 45 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | locoregional disease | NA | dead | 7.81 | Basal | European | TCGA.AR.A256.01A.11R.A169.07 |
TCGA-BH-A1F6 | 51 | female | White | Primary solid Tumor | not available | IDC | negative | negative | negative | NA | NA | dead | 8.12 | Basal | European | TCGA.BH.A1F6.01A.11R.A13Q.07 |
TCGA-BH-A1F6 | 51 | female | White | Solid Tissue Normal | not available | IDC | negative | negative | negative | NA | NA | dead | 8.12 | Basal | European | TCGA.BH.A1F6.11B.94R.A13Q.07 |
TCGA-BH-A1ES | 35 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | dead | 9.48 | NA | European | TCGA.BH.A1ES.01A.11R.A137.07 |
TCGA-BH-A1FC | 78 | female | Black or African American | Primary solid Tumor | postmenopausal | medullary carcinoma | negative | negative | negative | NA | NA | dead | 9.51 | Basal | African | TCGA.BH.A1FC.01A.11R.A13Q.07 |
TCGA-BH-A1FC | 78 | female | Black or African American | Solid Tissue Normal | postmenopausal | medullary carcinoma | negative | negative | negative | NA | NA | dead | 9.51 | Basal | African | TCGA.BH.A1FC.11A.32R.A13Q.07 |
TCGA-BH-A1FB | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 10.05 | NA | European | TCGA.BH.A1FB.01A.11R.A13Q.07 |
TCGA-BH-A1FB | 60 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 10.05 | NA | European | TCGA.BH.A1FB.11A.33R.A13Q.07 |
There are patients available from the BCN Tissue Bank that match the selected/a subset of the criteria. Explore the data available for these patients using our Sample Finder